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Binding kinetics of biomolecular interaction is of fundamental importance in 
advancing our understanding of numerous biological processes.  Most existing methods 
for kinetic measurement such as stopped flow and biosensor based devices (e.g. 
BIACORE) are expensive and/or require large sample volumes.  Poly(dimethylsiloxane) 
or PDMS based microfluidic devices offer a lower cost alternative with low reagent use 
and the potential for expanded applications.  In this project, I have developed the 
theoretical and experimental framework for kinetic rate measurement of immobilized 
biomolecules in PDMS microchannels.  The method employed is the displacement 
technique, where a labeled ligand is displaced from the binding site by an excess of 
unlabeled ligand. 
I began with the development of a theoretical model describing the transient 
convection, diffusion and dissociation of the labeled ligand from the immobilized 
receptors in a microchannel. The model was solved analytically and numerically. The two 
sets of solutions show a high degree of agreement. Simulation of the eluting time trace of 
the displaced labeled ligand was generated for a rational design of the flow displacement 
experiment, which predicts that the eluting fluorescence signal goes up with the increase 
in the length of channel and the decrease in flowrate used for introducing unlabeled 
ligand. Current detection instrument and microchannel design supports the measurement 
of dissociation kinetic rates ranging from 0.1-0.001 sec-1. 
Next, I carried out experiments in PDMS microchannel. Firstly, high affinity 
avidin-biotin system was employed to immobilize receptor protein onto PDMS wall. 
Biotin with a long linker was selected to ensure the accessibility of binding sites. Avidin 
 v
coating was confirmed via avidin-FITC.  The immobilization protocol was established by 
using fibrinogen labeled with both biotin and fluorescein. Fluorescence images 
demonstrate the feasibility of my protein immobilization strategy as well as the efficiency 
of the blocking buffer in suppressing nonspecific protein adsorption. Also, immobilized 
fibrinogen in microchannel was experimentally quantified.  
Secondly, an antigen-antibody system (insulin & anti-insulin IgG) and an 
enzyme-inhibitor system (aprotinin & trypsinogen) were selected as model binding 
systems. Biotinylated anti-insulin IgG was successfully immobilized with my established 
protocol, which was indirectly proven by the specific binding of insulin labeled with 
fluorescein. However, the immobilization of biotinylated trypsinogen was not as 
successful and no further study was conducted with this system. 
 Thirdly, a PDMS flow cell was fabricated to connect a microchannel with a fiber 
optic fluorescence probe for real-time monitoring of the displaced fluorescent molecules 
at channel outlet. It exhibits superior performance over the commercial flow cell with 
significantly reduced dispersion and protein adsorption along the flow path, while 
retaining acceptable detection sensitivity and ideal measurement linearity.  
Finally, flow-based displacement assay was performed in microchannel with 
insulin-antibody system. Although various flowrates were tested, no detectable 
displacement signal was observed at the channel outlet. One probable reason could be the 
mass transport limitation associated with slowly diffusing macromolecules, suggesting 
insulin-FITC might be too large to be displaced from the binding site by unlabeled insulin. 
This method is expected to be especially suitable for the study of low molecular weight 
biomolecules. 
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Chapter 1 Introduction 
Chapter 1  Introduction 
1.1  Biomolecular binding and kinetics 
Biomolecular binding is an extremely common and important phenomenon in the 
field of biochemistry, molecular biology and cell biology.  It is because the specific 
function of a given biomolecule can be realized only through its interaction with other 
molecules or cells [1].  Therefore many biomolecular interactions have been extensively 
studied; examples are protein-protein interactions, interactions of protein with small 
molecules including nucleic acids (DNA/RNA), sugar, lipids and carbohydrates.  
In spite of the diversified biological processes these intermolecular interactions 
are involved in, they bear the same hallmarks from the point of view of physical 
chemistry [2]. 
1. Specific binding - One molecule (ligand) can recognize and preferentially bind to 
its partner (receptor) with high selectivity and affinity. 
2. Noncovalent bond – One molecule interacts with the other one via noncovalent 
bond, including hydrophobic bonds, hydrogen bonds, electrostatic bonds and Van 
der Waals forces. 
3. Reversible process – Binding is reversible since the interaction partners are 
coupled via non-covalent bonds. Therefore binding is a dynamic process 
involving both association and dissociation.  
 
• Theoretical aspects of simple binding reactions 
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For convenience, the following discussion will use the term ligand-receptor to 
represent a typical interacting pair.  Relevant binding parameters are listed in Table 1.1. 
Table 1.1  Characteristic parameters of a binding system 
Parameter symbol Parameter Name Unit 
KA Equilibrium association constant    M-1
KD Equilibrium dissociation constant    M 
kon association rate constant M-1sec-1
koff Dissociation rate constant  sec-1
 
The simplest one-step binding scheme (one binding site, one conformational state)  
describes the association of a ligand L to the receptor R to form a complex RL, which 





L R RL                                                                  (1.1) 
As a reversible process, the receptor-ligand binding attains equilibrium. The rate 
of association (number of association events per unit of time) is typically proportional to 
[L]*[R]*kon. The rate of dissociation (number of dissociation events per unit of time) is 
proportional to [RL]*koff . Equilibrium is reached when the rate of association equals the 
rate of dissociation, therefore 
[ ] [ ] [ ]on offL R k RL k⋅ ⋅ = ⋅  













][][ ===⋅                                                      (1.2)        
where KD is the equilibrium dissociation constant, KA is the equilibrium association 
constant (or affinity constant), kon and koff are the association and dissociation rate 
constants, [RL] is the concentration of the receptor-ligand complex,  [L] is the 
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concentration of free ligand, and [R] is the concentration of free receptor. These 
concentrations (for dilute solutions) are measured at equilibrium. 
 
• Quantitative studies of biomolecular binding  
Biomolecular binding can be characterized in terms of the affinity and the kinetics 
of the interaction. The affinity constant (KA) gives a quantitative indication of how 
strong the interaction is between the receptor and the ligand. It is relatively easy to 
determine by various methods based on equilibrium binding assays, e.g. equilibrium 
dialysis, selective precipitation, gel filtration, ELISA- or RIA-based methods etc [4, 5]. 
However, affinity constant simply measures an equilibrium property of binding, 
which does not reflect the speed of association and dissociation process.  Kinetic 
analysis is more informative than affinity analysis by providing answers to how fast or 
slow the binding is. For instance, it was found that neuroreceptors have much more rapid 
binding velocity for their ligands than hormone receptors [3].  One of the central tasks of 
kinetic analysis is the determination of kinetic rate constant kon and koff.  Detailed review 
on kinetic study methods is given in chapter 2. 
1.2  Significance of measuring binding kinetics 
The significance of kinetic analysis lies in, but is not limited to the following 
areas. 
• Revealing binding scheme 
Determination of the association/dissociation constant is not the ultimate goal of 
kinetic study. The analysis of kinetic data along with the affinity data may help us to 
understand the underlying binding scheme. For instance, it was found that nicotinic 
 3
Chapter 1 Introduction 
acetylcholine receptor has two binding sites, two conformational states, and ligands bind 
to it in an ordered fashion, i.e. the ligand that binds first will dissociate last [3]. 
 
• Elucidation of  binding mechanism in combination with protein structural 
information 
Combination of high resolution protein structure information and its kinetic 
analysis data becomes a powerful tool for establishing binding mechanisms [6]. It is 
illustrated by the following example. Study by Brian C.C and James A W aimed at 
comparison of structural and functional epitope of human growth hormone (hGH) [7]. 
Site-directed mutagenesis was employed to assess the roles of 31 contact side-chains in 
modulating the binding kinetics. By measuring the change of kon and koff after converting 
each side-chain to alanine, they proposed that the binding complex of hGH and receptor 
is formed by diffusion and electrostatics mainly, which is stabilized by only a small 
portion of the contact side-chains. The finding suggests that the functional binding 
epitope is much smaller than the structural one, which predicts the possibility of 
designing smaller hormone analog.  
 
• A strategic tool in drug discovery 
 
The dissociation rate constant koff is considered to be the most critical value for 
the identification of a drug candidate [8]. Since many drugs are in nature enzyme 
inhibitors, the desirable candidates should exhibit slow dissociation (low koff values) 
which corresponds to longer half-lives of the inactive enzyme-inhibitor complex. We 
notice that dissociation constant KD is the ratio of koff to kon, different combinations of 
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koff and kon can give the same KD. Therefore, during screening, a judgment based on KD 
alone may possibly overlook those qualified drug candidates having both slow 
association rate and slow dissociation rate.  
Moreover, kinetic analysis also plays a role in drug design because kinetics has 
great impact on the functionality of a binding event [9]. It has proven to be a useful tool 
in drug design complementary to other structural analysis approaches, e.g. X-ray 
crystallography and NMR.   
1.3  Fluorescence technique 
Comparing with other detection methods such as absorbance or radiological 
measurement, fluorescence technique provides a cost-effective means to achieve high 
sensitivity while avoiding radioactive hazard [10]. These advantages make it an 
indispensable tool in many research fields including biochemistry and cell biology.  
Likewise, fluorescence is a preferred way of detection when it comes to lab-on-chip [11].  
The high sensitivity of fluorescence technique can be explained by the 
fundamental principle of a three-stage fluorescence process illustrated by Jablonski 
diagram (Figure 1.1) [12]. In excitation stage, photon of energy hυEX is absorbed by a 
fluorophore molecule to transform it from ground state S0 to excited state S1’. As a result 
of energy dissipation during the stage of excited-state lifetime, a photon of energy hυEM 
is emitted upon fluorophore’s returning to S0 in stage 3.   The lower energy of the emitted 
photon corresponds to a longer emission wavelength of the fluorophore. This difference 
between excitation and emission wavelength- termed Stokes shift- ensures emission 
photons to be recognized in contrast with low background, therefore serves as basis for 
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high sensitivity of fluorescence technique [12]. Another contributing factor is the high 
productivity of individual fluorophore molecule to generate thousands of photons. 
 
Figure 1.1  Jablonski diagram illustrating the fluorescence process. 
 
Generally fluorescence instrumentation consists of the following essential 
components (Figure 1.2): an excitation source, monochromators or filters for setting the 
desired excitation / emission wavelength, a detector (generally photonmultiplier tube) 
that converts detected photons into electrical signal or a photographic image, and a 
readout device [13]. For various purposes of study, four major classes of fluorescence 
instruments are being used so far, namely spectrofluorometer / microplate reader, 
fluorescent microscope, fluorescence scanner and flow cytometer [12].  
 
 
Figure 1.2  Components of a typical fluorescence instrumentation. 
 
1.4  Motivation 
In short, the motivation underlying the development of this microfluidic kinetic 
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On one hand, kinetic analysis is an important aspect in characterizing 
biomolecular binding (see 1.2). Current kinetic rate measurement mainly relies on 
expensive instruments such as stopped-flow and biosensor based devices (e.g. 
BIAcore®)(see chapter 2).  Besides, SPR detection principle and the instrument design 
limit its applications in studying interactions between cultured cells on solid support and 
ligands in bulk solution. These facts motivate us to propose a low cost method with the 
potential for expanded applications. 
On the other hand, microfluidic devices have provided an economical way to 
realize many biomedical applications. A detailed introduction to microfluidic device is 
given in Appendix 1. Particularly, there are several reasons making it an ideal tool for 
kinetic study [14]: 
1. The small dimension of microchannel ensures laminar flow condition. Therefore the 
prediction of mass transfer is straightforward via modeling.  
2. The much higher surface area to volume ratio of microfluidic channel as compared 
with traditional means (e.g. microwell plate) significantly improves the efficiency of 
bulk-surface interaction, leading to a much higher sensitivity.  
3. It is easy to integrate various analytical means into microfluidic device. Therefore it is 
possible to incorporate fluorescence technique for the purpose of high-sensitivity 
measurement.  
In spite of these specific advantages, there has been little work in the design of 
microfluidic devices for kinetic analysis of biomolecular binding. In this project, I 
present, to my knowledge, the first step towards this direction.  
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1.5  Objectives  
This project is aimed to develop a polymeric microfluidic device that allows the 
determination of dissociation kinetics of  biomolecular binding where one binding partner 
is immobilized to a microchannel surface. It will be achieved by real-time monitoring (at 
channel outlet) of the eluting fluorescent ligand dissociated from its bound receptor 
immobilized on microchannel wall, the process of which is induced by displacement with 
a nonfluorescent analog. The dissociation rate constant can be estimated by fitting the 
fluorescence data into a theoretical model describing the mass transfer and dissociation of 
the fluorescent ligand in microchannel. Specifically, the objectives set forth include: 
 
1. Develop a theoretical model describing transient convection, diffusion and dissociation 
of the fluorescent ligand in a rectilinear microchannel, which will be fitted into the 
experimental data later to determine the dissociation rate constant of a given binding 
system. Moreover, the model may provide guidance for an optimal experimental design. 
2. Find a robust method to immobilize receptor protein onto the surface of PDMS 
microchannel.  
3. Select model receptor-ligand binding systems to demonstrate the application of this 
microfluidic device for dissociation kinetic rate analysis. Establish an experimental setup 
for real-time monitoring of the eluting fluorescent ligand dissociated from the 
immobilized receptors upon displacement. Carry out the displacement assay with the 
selected example receptor-ligand systems and determine accordingly the dissociation 
kinetics by fitting the experimental data into the theoretical model.  
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1.6  Organization 
The rest of this thesis goes as follows. Chapter 2 briefly surveys conventional 
kinetic study methods, including label-dependent methods and label-free optical sensor 
based technique. Limited efforts on the development of microfluidic device for binding 
analysis are addressed as well. Chapter 2 also reviews protein immobilization methods 
on PDMS surface and introduces avidin-biotin capture system which is applied in my 
immobilization step. Chapter 3 illustrates the rationale of the proposed approach and 
develops a theoretical model describing mass transfer and displacement assay in 
microchannel. Analytical solution is derived and compared with numerical result. 
Simulation of displacement curve is generated with various operating parameters for a 
rational experimental design. Chapter 4 introduces main experiment materials and 
methods, including preparation of PDMS microfluidic device by softlithography, protein 
immobilization in microchannel, choice of example binding systems for kinetic rate 
measurement and flow-injection analysis (FIA) system setup. Chapter 5 presents and 
discusses experimental results of protein immobilization in PDMS microchannel and 
flow-based displacement assay conducted with insulin/anti-insulin IgG system. Chapter 
6 summarizes conclusions and recommends future work. 
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Chapter 2  Literature Review 
2.1  Label - dependent methods for kinetic analysis  
Although it is possible in certain cases to make use of the intrinsic fluorescence of 
native molecules for detection purpose [15], conventional experimental methods for 
studying binding kinetics usually employ radioactive- or fluorescent-labeled ligands.  
The main advantage of a radioactive label is that it does not change the kinetic 
properties of the ligand. In contrast, due to the larger size of fluorophore, a fluorescent-
labeled ligand may exhibit different kinetic behavior from its intact form.  Moreover, 
with numerous fluorescent probes on it, the labeled molecule could have a lowered 
binding specificity for its partner.  
Next I will introduce a few traditional techniques for kinetic analysis.  
z Stopped-flow (SF) spectrophotometry  
A widely used approach for solution-phase kinetic analysis is the integration of 
stopped-flow technique with different forms of spectrophotometry (absorbance, 
fluorescence) [16]. Fluorescence detection is often required due to its high sensitivity. 
Change of fluorescence should be observed upon the association of the two binding 
partners in the form of wavelength shift, fluorescence quenching, fluorescence transfer or 
fluorescence polarization [4].  
Figure 2.1 gives the schematic diagram of the experimental setup. For an 
automatic SF system, certain volume of ligand and ligate preloaded in the syringe are 
pushed into the mixer and then driven into the observation cell where bound and free 
ligand are observed together. The flow is stopped when the receiving syringe is filled and 
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in turn, triggers data acquisition. Therefore the output is a discrete time trace of 
spectroscopic signal at a set data acquisition rate.  Although fast reaction happening 
within ‘dead time’ (refers to the time between mixing and entering the observation cell) 
cannot be recorded, by adjusting sample concentration, SF is highly suitable for studying 
fast binding kinetics in the millisecond range [3].   
Due to the rapid response of SF technique, it has found many applications in 
analytical and bioanalytical chemistry. For example, it was successfully employed to 
measure nitrite concentration in natural and commercial drinking-water based on 
absorbance signal [17]. Gaikwad and co-workers combined SF and fluorescence 
polarization immunoassay to evaluate the potential of kinetic methodology in 
determination of drugs in biological fluids [18].  However, SF cannot be used when mass 
transfer is rate limiting.  
motor 
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• Filtration assay 
Filtration is a separation-based assay typically employing radioactive ligands. It is 
often performed in aliquot format. First, the binding partners of each aliquot are mixed, 
followed by an incubation step for a certain period of time set by user. Then the mixture 
solution is applied to a filter (usually glass fiber filter) to separate the bound and free 
ligand by filtration. The ligand bound to receptor is retained in the filter, while the free 
one passes through the filter into the filtrate. Next, free ligand amount can be determined 
from the radioactivity of the filtrate, and bound one from either radioactivity of retentate 
or from the difference between initial ligand amount and free one. As a result, each 
measurement data point corresponds to a certain time of incubation.  
Obviously this method is limited by the low time resolution attributing to the 
mixing and filtration step during which further association could happen. Therefore it 
cannot be used for fast reaction. Another application limitation comes from the cutoff 
size of the filter [3]. 
• Temperature-jump 
Temperature-jump (also termed relaxation kinetics) approach [3] is advantageous 
in tracking extremely fast binding kinetics in microsecond time range. After the binding 
equilibrium is reached by incubating the binding partners in solution, a rapid increase in 
temperature (‘T-jump’) is applied so that the established equilibrium is disturbed. Then 
the following binding reaction is recorded in terms of spectroscopic signal until a new 
equilibrium is achieved.  The application of this method is usually confined to very fast 
binding system as interference signal may be introduced by thermal convection in 
minutes.   
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2.2  BIAcore – Label free biosensor technique 
2.2.1  Introduction 
So far a few label free biosensors have been developed for real-time monitoring 
of biomolecular interaction happening at sensor surface. The detection principles of these 
biosensors are based on surface plasma resonance (SPR, BIAcore) or a resonant mirror 
(IAsys, Fisons) or piezoelectric based microbalance. For all the three, a mass change 
induced by association or dissociation of molecules from the sensor surface will be 
transformed to various forms of detectable optical or electrical signal.   
BIAcore®  system is the first commercial application of SPR since about 1990 
which has proved to be a popular tool for understanding biomolecular interaction, 
including the measurement of binding affinity (strength) and kinetics (speed) [19]. This 
review will focus on BIAcore as a benchmark system, since this proposed system shares 
many similarities with BIAcore such as the flow-through system setup and basic kinetic 







Figure 2.2  Schematic of the microfluidic device of BIAcore system. 
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SPR detection, sensor chip and microfluidics techniques form the fundamental 
basis of this automatic biosensor system [20].  
• SPR detection (refer to [1] for principle of detection) 
• Sensor chip 
As a core component, the sensor chip is not only the platform for biomolecular 
interaction, but also a signal transducer to transform the mass change signal to SPR 
signal [1]. It is a glass chip coated with a thin gold layer (50 nm thickness) on one side. 
A modified dextran matrix is covalently linked to the gold film for further 
immobilization of ligand molecules.  
• Microfluidic device (Figure 2.2) 
The binding partner in solution is injected into a flow cell on the sensor surface, where it 
interacts with the immobilized ligand. The flow cell is formed by pressing an integrated 
microfluidic cartridge (IFC) against the sensor surface. Here microfluidic channel is 
employed to achieve efficient mass transfer [15]. 
Major differences distinguishing BIAcore from conventional methods are listed 
below. 
1. As opposed to conventional methods which rely on radioactive- or fluorescent-label to 
‘see’ binding events, optical sensors allow direct sensing of binding events without the 
use of labels. A distinct advantage, as a consequence of leaving the ligand intact, is to 
ensure an unchanged kinetic binding property.  
2. By using conventional methods, kinetic study is carried out with both the binding 
partners present in solution. Whereas in the case of biosensor, one biomolecule is 
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immobilized on a solid sensor surface and the other partner in solution flows through the 
surface to interact with the immobilized one [16].   
3. Biosensor-based kinetic measurement consumes less sample and shorter analysis time 
[1].  
2.2.2  Kinetic experiment procedures 
Experiments for kinetic analysis with BIAcore involve two steps. First step is the 
immobilization of ligand on the sensor chip surface. Second step is the measurement of 
interaction.  
• Immobilization  
Commercially available sensor chips are generally based on a 
carboxymethyldextran matrix (Sensor Chip CM5 from BIAcore, shown in Figure 2.3).  
It is achieved by surface modification of gold film with dextran polymer chains via a 
self-assembled monolayer (SAM) of linker molecule. This hydrogel-like dextran layer 
provides a flexible, three-dimensional structure and is superior to flat surface in terms of 
low non-specific binding and better preservation of binding activity for immobilized 
ligand [16]. This sensor chip is mainly intended for covalent immobilization through 
amine group, and also can be further modified for thiol or aldehyde coupling [21]. 
In addition, sensor chips for non-covalent attachment of ligand are also provided. 
One example is Sensor Chip SA, which has avidin immobilized on the dextran matrix 
for capturing biotin-conjugated ligand with high affinity [1].  
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dextran linker
carboxymethyl group 
alkanethiol monolayer gold surface  
Figure 2.3  Schematic representation of a sensor surface designed for covalent 
immobilization of molecules [22]. 
 
• Measurement of interaction [1] 
A typical interaction measurement is composed of three stages: association, 
dissociation and regeneration. Association test is started by the continuous injection of 
sample to the sensor surface prepared with immobilized ligand. Increased resonance 
signal from baseline should be observed during binding until equilibrium is reached. 
Then dissociation is initiated by replacing sample with running buffer and the resonance 
signal decreases over time. Finally regeneration is done with certain regeneration buffer, 
with the purpose to fully remove the bound analyte from the immobilized ligands so as to 
prepare the sensor surface for the next cycle of measurement. A typical sensorgram of 
binding is given in Figure 2.4.  
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Figure 2.4  A typical BIAcore sensorgram [22].  
 
2.2.3  Applications 
Briefly, BIAcore has been used to probe molecular interaction, monitor and 
evaluate molecular binding kinetics and affinity, measure reagent concentration and 
screen for binding partners and so on.  Types of biomolecular interactions involved are 
protein-protein, protein-peptide, protein-DNA, and protein-drug interactions etc. 
Interactions between nuclear acids (DNA, RNA) are also addressed in the investigation 
of replication, transcription and translation.   
With the help of BIAcore, Glaser et al identified the unusual kinetics of the 
interaction between HIV p24 core protein and a monoclonal antibody [23]. The biphasic 
association phase and mono-exponential dissociation one implies a reversible change of 
binding efficiency in the epitope region which could be the result of conformation change 
of antigen.  In another experiment, BIAcore was engaged in monitoring the interaction 
between endotoxin and polymyxin B (PMB), a peptide antibiotic to treat endotoxicosis 
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mimics, it was concluded that despite the comparable binding affinity for endotoxin, it is 
PMB but not those synthetic analogs that sequesters the endotoxin beyond binding. The 
finding elucidated the mechanism behind endotoxin neutralization by PMB which had 
remained obscure for thirty years. 
2.2.4  Comparison between BIAcore and fluorescence-based microdevice 
z Commonness 
Both BIAcore and this proposed microdevice require one of the binding partner is 
to be immobilized on a solid surface, and the other one flow over the surface through the 
microfluidic channel during which interaction occurs. Real time monitoring is another 
similarity. 
Some studies reported that kinetic rate measured with BIAcore was lower than 
that obtained from using conventional solution phase method such as stopped-flow [1]. 
Consequently a dispute was triggered regarding whether solid-phase assay yields true 
values of binding parameters. In spite of these, it is agreed that in certain cases when cell 
surface receptors or surface antigens are subjected to study, solid phase assay provides 
more accurate measurement.  It is because the immobilized receptors or antigens behave 
more closely to their native form in terms of rotation and diffusion than those in solution 
[4]. 
z Differences 
The fundamental difference in detection principle of the two systems determines 
their respective advantages and disadvantages (Table 2.1). As BIAcore is sensitive to the 
changes in mass, the binding of small size molecules is hardly detected. For SPR sensors, 
the lower limit of detectable molecular weight is ~180 Da [25].  Fluorescence-based 
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microfluidic device does not have this trouble. However, fluorescence label must be 
introduced. Another advantage of this proposed system is the potential application in 
measuring dissociation rate of ligands for cultured cells in microchannel. It is difficult to 
implement with BIAcore as it is not designed for cell culture purpose. Moreover, the 
short SPR penetration depth (300 nm) prevents it from such studies involving 
immobilized cells.  





Optical detection principle change in mass fluorescence 
Detectable mass limit yes no 
Need of labeling no yes 
Sensorgram meaning 
association/dissociation event 
detected on surface 
dissociated ligand 
detected at outlet 
Measured Parameters kon, koff koff
Instrument cost 
high  (more than US$200,000 
for BIAcore 2000) 
low 
Flexibility fixed 
can be adapted for 
many applications  
Possibility of studying 
interactions between ligand 
and cultured cell 
difficult possible 
 
2.3  Exploration of binding analysis with microfluidic device 
Regardless of many attractive properties of microfluidic system with respect to 
binding kinetics analysis (see 1.4), previous work mainly addressed measurement of 
binding affinity rather than that of kinetic rate. For instance, Chiem and Harrison 
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estimated association constant KA of a monoclonal antibody to BSA labeled with FITC 
by separation of free and bound BSA-FITC with capillary electrophoresis in 
microchannel [26]. Cremer’s group determined the affinity constant of DNP/anti-DNP 
system via a solid-phase immunoassay [27]. DNP-conjugated lipid bilayer was coated on 
PDMS surface, fluorescein-labeled anti-DNP of various concentrations was then parallel 
injected through multiple channels. Surface-bound anti-DNP in all the channels was 
simultaneously measured from a line-scan image obtained with total internal reflection 
fluorescence microscopy (TIRFM).  
One unique report I found relevant to kinetic study did not concern specific 
binding of biomolecules, but reflected the desorption kinetics of fibrinogen from silica 
surface induced by displacement with more strongly adsorbing proteins in human plasma 
[28]. Desorption of fluorescein-labeled fibrinogen was monitored by TIRFM as a 
function of time. The experimental data was fitted to a double exponential function (Eqn 
2.1), implying there are two populations with distinct removal rates. One is fast and the 
other is slow.  
1/
1 2
ty a e a e 2/tτ τ−= + −                                                                                  (2.1) 
where y is fluorescence intensity, t is time, a1 and a2 are population fractions satisfying 
a1+a2=1, and 1τ and 2τ are time constants. 
2.4  Protein immobilization methods on PDMS surface 
• Protein immobilization on solid support 
Immobilization of protein onto a solid support is the first step in many bioassays. 
Existing methods can be mainly classified into two categories: 1) noncovalent 
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immobilization via physical adsorption; 2) covalent attachment of protein to modified 
surface [29, 30].   
Physical adsorption, as the simplest method, immobilizes protein onto the solid 
surface via noncovalent forces involving hydrophobic forces, electrostatic forces, 
hydrogen bonds and van der Waals forces etc. Whereas covalent immobilization formed 
by chemical reaction provides stronger attachment than absorbed layer, but always 
involves complicated surface activation steps. The methods are compared in Table 2.2. 
Table 2.2  Comparison of immobilization methods on solid support 




- low specificity 
- blocked binding sites 
- denaturation risk 
Surface 
activation 
covalent stable sophisticated reactions 
 
• Protein immobilization on PDMS surface 
The main factor affecting my choice of the immobilization strategy is the material 
used for fabrication of microchannel. My microchannel is made of poly(dimethylsiloxane) 
(PDMS), a popular material for microfabrication of biochip. The relevant surface 
chemistry properties of PDMS are [31, 32]: 
1. It is extremely hydrophobic. This property facilitates high degree of non-specific 
adsorption of protein. 
2. It is chemically inert; the lack of functional groups makes the covalent immobilization 
of proteins on PDMS surface much more difficult than glass or silicon.  
3.  Its surface property is not constant under ambient conditions. 
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Over the years, various surface modification approaches have been attempted, 
such as exposure of PDMS to energy source like oxygen plasmas followed by 
silanization, or chemical vapor deposition [33].  In spite of these efforts, problems still 
exist for covalent immobilization as a result of surface reorganization feature of PDMS 
[33]. It is found that the introduced functional groups on the surface can be readily 
submerged by the small chains migrated from the bulk PDMS, rendering this approach 
less reliable.  Apart from the above traditional methods, immobilization via phospholipid 
bilayer coated on PDMS was demonstrated by Cremer’s group, which exhibited such 
desirable behaviors as improved specificity and reduced denaturing effect [27]. However, 
the stability of the lipid bilayer has not yet been determined.  
Based on the above considerations, I choose physical adsorption, the most 
straightforward method, for my immobilization step. Previous work from our lab had 
investigated flow-induced protein adsorption in microchannel and confirmed that 
multiple layer adsorption had occurred for example proteins [34].  
 
• Problems associated with nonspecific adsorption 
Obviously kinetic analysis requires that active binding sites on protein must be 
fully accessible upon immobilization. However, with physical adsorption method, protein 
molecules adhere to the surface in a random manner as illustrated in Figure 2.5. The 
random orientation may have their binding sites blocked by surface and cause the protein 
to lose its binding ability to ligand. More seriously, some protein may undergo partial 
denaturation [4]. Monoclonal antibodies directly attached to solid surface were reported 
to have much lower binding affinity, namely antigen capture capacity (AgCC) [35, 36]. 
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This adsorption-induced denaturation could be explained as the tendency of the protein to 
expose more residues from its interior to form more attachment points on the surface. 
 
Figure 2.5  Antibody nonspecifically adsorbed on PDMS surface. 
 
One solution to this problem is to replace the direct nonspecific adsorption 
method with an indirect affinity capture technique using biotin-avidin system [30, 37]. 
Details will be described in next section.  
2.5  Application of avidin-biotin capture system in protein 
immobilization  
In this project, I used avidin-biotin capture system with the purpose to ensure the 
accessibility of the binding sties on receptor molecules upon immobilization.  
Avidin is a highly stable tetrameric glycoprotein composed of four identical 
subunits. Each subunit contains a binding site for biotin [38]. The avidin molecule is in a 
cubelike shape (~6.0 x 5.5 x 4.0 nm), assuming a symmetrical structure of two opposing 
faces with two biotin-binding sites on each of the face (Figure 2.6A). The extremely 
strong interaction between avidin and biotin (KA=1015 M-1) guarantees essentially 
irreversible immobilization of the target protein, which makes it a powerful tool in many 
areas of biochemistry, such as immunoassay, affinity chromatography etc [39]. 
In my system, biotin-labeled receptor is immobilized on PDMS surface via the 
following procedure: 1) label target protein with biotin, 2) coat PDMS surface with 
avidin, 3) allow the biotinylated protein to bind avidin. This indirect immobilization 
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method allows the active binding sites on the receptor freely accessible to its binding 
partner (Figure 2.6B). There are many advantages offered by this immobilization strategy: 
1. Due to the highly stable structure, avidin is found to retain its specific binding ability 
to biotin after adsorbing on PDMS surface [40]. 
2. Conjugation chemistry of biotin to protein is very mature and straightforward.  
3. Users have the freedom to choose biotin with optimal spacer arm length. (More details 
will be provided in Chapter 4.) 
 
 KA = 1015 M-1












Figure 2.6  Immobilization of antibody via avidin-biotin system. (A) Illustration of high 
affinity binding between avidin and biotin (adapted from [38]). (B) Indirect 
immobilization via avidin-biotin system (left) vs. direct immobilization (right). 
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Chapter 3  Theoretical Modeling 
3.1  Modeling of flow-based displacement assay in microchannel 
In this project, the displacement experiment is carried out in single rectilinear 
(straight) channel of large aspect ratio (the ratio of width to height) (see 4.1). 
Experimental procedure (shown in Figure 3.1) is briefly described as follows. 
Fluorescein-labeled ligand is injected into the microchannel prepared with immobilized 
receptors on the walls via avidin-biotin capture system.  After reaching binding 
equilibrium, free fluorescent ligand is removed by running buffer. Next, displacement is 
carried out by constantly introducing an excess of unlabeled ligand. Consequently, the 
previously bound fluorescent ligand is dissociated from the receptor and replaced by the 
unlabeled ligand.  These freed fluorescent ligands are transported downstream through 
the channel and the eluting ligand is monitored real-time at the channel outlet.  
 
 
Figure 3.1  Schematic of displacement of labeled ligands by introducing 
unlabeled ligands into a microchannel (only the molecules on the lower half of 
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Figure 3.2  Coordinate system for modeling 
 
z Assumptions 
A theoretical model depicting mass transfer in combination with displacement-
induced dissociation of fluorescent-ligand in the parallel-plate microchannel is developed 
under the following simplifying assumptions.  
1. The transport process is transient and two-dimensional (W>>H). 
2. No dispersion.  
3. Displacement of bound fluorescent ligand occurs throughout the channel as soon as the 
nonfluorescent ligand is introduced (t >0).  
4. Uniform velocity (as opposed to parabolic flow profile). 
z Governing equation  
Under the assumptions stated above, the governing equation based on 




















C                                                                          (3.1) 
where  is the dimensional concentration of the free fluorescent ligand in microchannel 
as a function of and , u is flow velocity, and D is the diffusivity of the fluorescent 
ligand. This is a two-dimension model which applies when channel W>>H (high aspect 
Cˆ
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ratio) so that diffusion along W can be ignored. This condition is satisfied in the case of 
my channel design (aspect ratio = 8)  (see 4.1). 
z Initial condition 
Initially the channel is filled with buffer only, and all the fluorescent ligands are 
bound to the immobilized receptors without any dissociation, i.e., 
ˆ ˆ ˆ ˆ( 0, , )C t x z= 0=                                                                                    (3.2) 
z Boundary condition 1  (B.C.1) 
As fluorescent ligands will not be introduced from the inlet during displacement, 
the concentration there is zero, i.e., 
ˆ ˆ ˆ ˆ( , 0, ) 0C t x z= =                                                                                    (3.3) 
z Boundary condition 2  (B.C.2) 
Flux at the center of the channel is zero, i.e., 
ˆ
ˆ ˆ ˆ( , , 0) 0
ˆ
CD t x z
z
∂− =∂ =                                                                           (3.4) 
z Boundary condition 3  (B.C.3) 
Flux of the free fluorescent ligand at the channel wall ( ˆ halfz H= ) equals the rate 
of the concentration change of the bound ligand on channel surface induced by 
displacement, i.e.,  
ˆˆ
ˆ ˆ ˆ( , , ) ˆˆ
b
half
dCCD t x z H
z d
∂− = =∂ t                                                                (3.5) 
where is half height of the channel, and is the surface density (moles/mhalfH ˆbC
2) of the 
fluorescent ligand bound to the immobilized receptors.  
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As displacement by the introduction of unlabeled ligand prevents the rebinding of 
the dissociated fluorescent ligand, only dissociation occurs. Therefore dissociation of 







= −                                                                                        (3.6) 
In addition, by definition, dissociation rate constant koff is the probability of 
dissociation per unit time, thus and kˆbC off can be related by the probability of 














∫∫ −=     →                                        (3.7) )ˆexp(ˆ 0 tkCC offb −=
where C0 is the initial surface density (moles/m2) of the receptor-bound fluorescent ligand.  






∂−                                         (3.8)       
With the above initial and boundary conditions, partial differential equation 
Eqn3.1 can be solved analytically or numerically. Concentration of the free fluorescent 




LC ˆ ˆ ˆ ˆ( , , )C t x z
xˆ L= ) across  to yield a function of time.  zˆ
3.2  Analytical solution to the model (constant u) 
Make Eqn 3.1-3.4, and 3.8 dimensionless using the following dimensionless 
quantities 
0
ˆ ˆ ˆˆ, , ,half
half
C H u xC t t x z
C L L
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Peclet number  
2
, ,half off
uH LPe Pa k
DL u
= =  
where  is the initial surface density (moles/m0C
2) of the fluorescein-labeled ligand bound 
to the immobilized receptors in a microchannel.   We get   











C              (3.9) 
Initial condition (I.C.):    0),,0( == zxtC               (3.10) 
Boundary condition 1 (B.C. 1): 0),0,( == zxtC                    (3.11) 
Boundary condition 2 (B.C. 2): 0)0,,( ==∂
∂ zxt
z
C               (3.12) 
Boundary condition 3 (B.C. 3): ( , , 1) PatC t x z PePa e
z
−∂ = = ⋅∂                (3.13) 
Recall that during development of the theoretical model, one simplifying 
assumption is that displacement of the bound, labeled ligand throughout the microchannel 
occurs immediately when flow starts (see 3.1). However, actually the displacement at 
certain position within the channel will not happen until the flow front of the unlabeled 
ligand reaches there. To account for this time delay in displacement, an improved B.C.3 
can be written as 
   B.C.3’                    ( )( , , 1) ( )Pa t xC t x z PePa e u t x
z
− −∂ = = ⋅ −∂                           (3.14) 
where is a unit step function.  ( )u t x−
Solve the above dimensionless governing equation analytically with the aid of 

















































zxVzxsV                                                          (3.15) 
where we apply I.C. and  
∫∞ −== 0 ),,()},,({),( dtzxtCezxtCLtzxV st  
The Laplace transform of the boundary conditions are as follows, 
B.C. 1:   0)},0,({)(),0( ===== zxtCLtzfzxV                                                  (3.16) 






zxV                                            (3.17) 
B.C. 3:   
0
( , 1) { ( , , 1)} Pat stV x z C PePaLt t x z PePa e e dt
z z P
∞ − −∂ = ∂= = = ⋅ ⋅ =∂ ∂ ∫ a s+             (3.18) 
According to Laplace transform property 
{ } )()()(1 ααα −−=−− tUtfsFeL s  with ttf ;0)( = <0 
Laplace transform of B.C.3’ is derived from Eqn 3.18 
B.C.3’:  2
( , 1) ( ) sxV x z PePag x e
z Pa s
−∂ = = =∂ +                                                                 (3.19) 









∂                                                                   (3.20) 
where     sb
Pe
a −== ,1 . 
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Then referring to second boundary value problem in [42], solution to the partial 
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Substitute and  (Eqn 3.16,3.17,3.19) into Eqn 3.21  results in )(),( 1 xgzf )(2 xg
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z Verification of analytical solution by checking the mass balance for labeled 
ligand 
Experimentally, total moles of eluting labeled ligand can be estimated by 
* 02( 2 )L halfM W H L n C= + ⋅ ⋅  
where n is the valency of a given binding system. Let n = 1 for all calculations, then 
* 2( 2 )L half 0M W H L C= + ⋅                                                                                       (3.23) 
Theoretically,  is calculated as follows based on the analytical solution of  
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half 0 half2(W 2H ) LC    (when W 2H  )≈ +                                                        (3.24) 
3.3  Analytical and numerical solution comparison 
The above theoretical model was also solved numerically under the same 
assumptions and boundary conditions (done by Dr Partha Roy). Based on the current 
channel dimensions (35 mm (L) x 240 μm (W) x 30 μm (H)), the eluting time trace of 
displaced labeled ligand generated from the analytical solution (Eqn 3.22) was compared 
with that from the numerical solution. In the overlapped graph (Figure 3.3), the two sets 
of solutions are almost consistent for all the data points, demonstrating reasonably good 
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agreement between the analytical and numerical solution. The numerical calculations 
were also carried out for the parabolic velocity profile and the resultant values are within 
5% of the analytical values (data not shown). 
dimensionless time (t)



























Figure 3.3  Analytical and numerical solution comparison. (2Hhalf =30 μm,  
W=240 μm,  L=35 mm,  Q=1 μL/min,  koff=0.1 s-1) 
 
3.4  Simulation of displacement curve for experimental design 
The theoretical model established above not only provides the insight into the 
displacement process in the microchannel, but also the guidance for a rational 
experimental design.  Optimal experiment conditions could be determined by examining 
the displacement curves with various set of parameters.  
The main concern during my experimental design is how to get detectable signal 
at the channel outlet that largely depends on the detection limit of the fluorescence 
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measurement instrument, which in my case is 10 nM for FITC (see Appendix 7). 
Therefore it is necessary to find the optimal experiment conditions to generate the 
displacement signal sufficiently high above the detection limit.  outletLC *
The analytical solution to the model has suggested the dependency of on Pa 
(Eqn 3.22), which is determined by k
outlet
LC *
off, L and u. Obviously L and u are the adjustable 
parameters in design, while koff  of a given binding system is an unknown factor. To probe 
systems with different dissociation speed, three typical koff  (0.1, 0.01, 0.001 s-1) are 
evaluated in the following simulation.  
z Simulation of the time trace of the displaced labeled ligand for current 
microchannel design 
The microchannel currently in use has the dimensions 35 mm (L) x 240 μm (W) x 
30 μm (H) (see 4.1). According to a quantification experiment result for immobilized 
protein in this channel design (see 5.1.2.2), the initial surface density (C0) of the bound 
fluorescent ligand is about 0.01058 nmole/cm2.  Based on these known values and the 
analytical solution (Eqn 3.22), theoretical displacement curves with various koff and flow 
rate are presented in Figure 3.4, and relevant parameters are calculated (Table 3.1).  
As reflected by the simulation graph, slower flow rate gives higher measured 
signal. For rapid dissociating system (koff = 0.1 s-1), all the three tested flow rates are 
applicable. Whereas, for slow dissociating system (koff = 0.001 s-1), only the slowest one 
(1 μL/min) generates detectable signal.  Therefore by choosing appropriate flow rate, it is 
feasible to use the current channel design to measure dissociation kinetics of the binding 
system whose koff ranges between 0.1-0.001 s-1. Multiple flowrates may be used to 
confirm one koff value. 
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Figure 3.4  Simulation of the time trace of the displaced labeled ligand for 
current channel design, showing dimensional outlet concentration outletLC *ˆ  (nM) as 
a function of dimensionless time t for binding system of dissociation rate 
constant koff  (A) 0.1 s-1, (B) 0.01 s-1 and (C) 0.001 s-1 . 
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Table 3.1  Parameters used in simulation of the time trace of the displaced 
labeled ligand for current microchannel design 
koff  (s-1) flowrate Q 
(μL/min) 
velocity u  
= Q/(WH) 
(cm/s) 
Re =  
ρdu/η  *
Pa =  
koff L/u 
Pe =  
(uHhalf2)/(Dinsulin L) ** 
1 0.2315 0.123 1.5120 0.1154 
5 1.1574 0.615 0.3024    0.5768 
0.1 
10 2.3148 1.230 0.1512 1.1536 
1 0.2315 0.123 0.1512    0.1154 
5 1.1574 0.615 0.0302 0.5768 
0.01 
10 2.3148 1.230 0.0151 1.1536 
1 0.2315 0.123 0.0151    0.1154 
5 1.1574 0.615 0.0030    0.5768 
0.001 
10 2.3148 1.230 0.0015 1.1536 
 
* Re = ρdu/η is calculated by taking the following parameters: 
ρ -  density of water   (1 g/cm3) 
η – dynamic viscosity of water @ 20oC   (1.002 cP = 1.002  g/m sec) 
d – hydraulic diameter of the rectangular channel 
      d = 4A/p = 2 WH/(W+H) = 2*(240*30)/(240+30) = 53.3  μm 
** Pe is calculated based on diffusivity of insulin  (Dinsulin = 12.9x10-7 cm2/s @ 20oC). 
 
z Simulation of the time trace of the displaced labeled ligand for longer channel 
design 
For a binding system with extremely slow dissociation rate, current design may 
not be able to produce detectable displacement signal. In this case, enhanced sensitivity 
could be obtained by increasing the length of the microchannel so as to give a greater 
surface area for immobilizing more molecules, and in turn more dissociated ones upon 
displacement. However, this solution will bring other problems such as elevated 
consumption of immobilized receptors, and more serious dispersion along the channel. 
So there has to be a trade-off between channel length and detection sensitivity. See 
Appendix 2 for results. 
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Chapter 4  Experiment Materials and Methods 
4.1  Preparation of PDMS microchannel by soft lithography 
Poly(dimethylsiloxane) (PDMS) is a widely used material for microfluidic chip 
for many advantages of it, such as low-cost, nontoxicity, biocompatibility, transparency 
and ease of fabrication [43, 44].  
In this project, soft lithography technique was used to fabricate PDMS 
microchannels [45]. Glass master, which was used as a casting mold for PDMS, was 
prepared as follows. The substrate is spun cast with photoresist (SU-8 negative tone), 
covered with a computer-designed mask, and exposed to ultraviolet (UV) irradiation. The 
photosensitive material crosslinks when exposed to UV radiation. For negative resist, the 
developer solution removes unexposed material. A master mold is formed. The master 
fabrication was done by Lim Cheetiong. 
Next step is replica molding of PDMS microfluidic channels (Figure 4.1 A) with 
the following procedure: 
1. Coat the glass master with silane (tridecafluoro-1,1,2,2-tetrahydro octyl trichlorosilane 
from Sigma-Aldrich, Germany) to passivate the surface and facilitate removal of cured 
PDMS.  
2. Mix PDMS prepolymer and curing agent (Sylgard 184 silicone elastomer kit, Dow 
Corning, Midland, MI) in a 10:1 ratio.  
3. Degass the above mixture in a vacuum dessicator to remove air bubbles generated 
during mixing. 
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4. Pour the degassed mixture over the glass master with a shape ring to confine it to the 
area of channel features, then cure it at 65 °C for 1.5 hours. 
5. Peel the PDMS film from the master after curing. Cut it into a rectangular slab 
containing five straight channels on one side.  
6. Punch inlet and outlet holes (1.08 mm i.d.) for the purpose to connect this 
microchannel to external fluid source later.   
7. The channel piece obtained from step 6 is sealed against another piece of cured flat 
PDMS to form a sealed device (Figure 4.1C,D). It is done by exposing the two pieces 
(channel side facing upward) to air plasma (plasma cleaner, Harrick Scientific, NY) for 
3-4 minutes. Immediately after plasma oxidization, the channel piece is brought into 
contact with the flat sheet to form an irreversibly sealed homogeneous PDMS 















Figure 4.1  Preparation of PDMS microchannel. (A) Schematic of replica molding of PDMS 
microchannels. (B) Schematic of top view of a microchannel. (C) Cross section view of a 
microchannel. The arrows indicate flow direction. (D) Photograph of my microfluidic chip 
composed of 5 identical rectilinear channels of dimensions: 35 mm (L) x 240 μm (W) x 30 μm 
(H). 3rd channel is connected to inlet and outlet tubing. 
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The fabricated master has five identical rectilinear channels on it, and each 
microchannel has typical dimensions of 35 mm (length) x 240 μm (width) x 30 μm 
(height), which gives high aspect ratio (240 μm:30 μm = 8:1). The thickness of the 
channel layer and flat layer is 4mm and 1mm respectively. 
4.2  Protein Immobilization in microchannel 
4.2.1  Immobilization principle and key reagents 
As mentioned in 2.5, immobilization of protein via avidin-biotin capture system 
has many advantages over direct physical adsorption (Figure 2.6). Therefore in this 
project, this indirect approach was used to immobilize receptor protein to PDMS channel 
wall (see 2.5 for principle). Listed below are the key reagents involved in this step.  
• Fibrinogen as a test protein 
My target binding systems for measuring kinetic rate involve protein of high cost 
such as purified antibody or cell receptor. It is preferable to find an economical way to 
test my immobilization method with a suitable substitute protein. The comparable size of 
fibrinogen (340 kDa) and its low cost makes it a good substitute for antibody or receptor. 
Plus, the robustness of the immobilization system can be proved if it can successfully 
capture protein of such size. Fibrinogen is a plasma protein involved in coagulation 
cascade. Its hydrodynamic radius is estimated at 10 nm with Stoke’s-Einstein equation. It 
was purchased from Fluka (Buchs, Switzerland). 
• Avidin 
Avidin (Sigma-Aldrich, Germany) coating on PDMS plays two roles during the 
immobilization procedure. On one hand, it serves as an anchor layer to capture the biotin-
labeled biomolecules. On the other hand, this protective coating is a surface modification 
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step in my blocking strategy to minimize nonspecific protein adsorption on PDMS (see 
Blocking buffer subsection). Using avidin as a blocker molecule has many benefits: 1) 
the cubic shape of avidin ensures to build a compact shield layer covering the underlying 
PDMS, with little interspaces for molecules to pass through; 2) the high isoelectric point 
(PI =10) of avidin prevents its nonspecific interaction with the analytes present in 
solution due to the high repulsive forces [46].  
• Reactive biotin derivative with long spacer linker 
To label a target protein with biotin, amine-reactive ester NHS-PEO4-Biotin 
(Pierce, Rockford, IL) with spacer arm length of 29 Å was selected to minimize steric 
hindrance effect. The long and flexible PEO spacer linker helps to raise the target protein 
to some distance away from the surface so as to leave the active binding sites on the 
protein fully accessible to its binding partner in solution. In addition, the PEO spacer arm 
imparts water solubility to this biotin derivative, which allows biotinylation to proceed at 
neutral PH. This is particularly useful for the biotinylation of sensitive proteins such as 
antibody, enzymes or cell receptors when mild reaction conditions are required. Reaction 

































biotin conjugated protein 
Figure 4.2  Reaction of biotin with protein. 
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• Reactive fluorescein derivative 
To label protein with fluorescent dye, I used fluorescein-X succinimidyl ester 
(Molecular Probes, Eugene, OR). This fluorescein derivative contains a spacer between 
the fluorophore and reactive group that minimizes fluorescence quenching resulting from 
conjugation. Moreover, conjugates prepared with it exhibit higher fluorescence intensity 
than those labeled with fluorescein isothiocyanate (FITC) [12]. Figure 4.3 shows the 
excitation and emission spectra of fluorescein. 
350 400 450 500 550 650600
fluorescence em issionabsorption
W avelength (nm )  
Figure 4.3  Absorption and fluorescence emission spectra of fluorescein (in pH 
9.0). 
• Blocking buffer 
Nonspecific protein adsorption is a well-known problem in solid-phase 
biochemical analysis [47, 48]. The sensitivity of an immunoassay depends on the 
effectiveness of reducing nonspecific binding of analyte or secondary antibody [49]. 
The degree of nonspecific protein adsorption is partially determined by surface 
property of the solid support. PDMS usually causes strong protein adsorption due to its 
high hydrophobicity [50]. It was found that standard blocking cocktails commonly used 
for ELISA (done with polystyrene microwell plate) do not give sufficient adsorption 
reduction for PDMS microchannels [47]. Therefore, to carry out specific binding assay in 
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PDMS microchannel, it is necessary to figure out an efficient blocking strategy 
applicable to this particular material. 
In this project, I proposed a blocking strategy composed of two steps. First step is 
the surface chemistry modification by coating multiple layers of avidin on PDMS. 
Second step involves a modified-version of the blocking buffer reported by Leckband’s 
group [47]. It was used as dilution buffer for preparing receptor and ligand solution 
immediately before flow experiment. 
4.2.2  Verification of avidin coating in microchannel  
As the first step of immobilization, irreversible avidin adsorption on the walls of 
PDMS channel needs to be confirmed before carrying out the following steps.  
For detection purpose, avidin (10 mg/mL in PBSA) was labeled with fluorescein 
with molar ratio of fluorescein:avidin = 5:1. The reaction mixture was incubated at room 
temperature (RT) for 1 hr with continuous shaking, followed by incubation overnight at 
4oC. Free fluorescein was removed by gel filtration (Sephadex G-25), and purity was 
checked by HPLC (macrosphere GPC column, Alltech, IL).  
Dynamic coating was done by perfusing microchannel with avidin-FITC (5 
μL/min) for 1 hr. Two different concentrations (100 nM and 1 μM) of avidin-FITC were 
tested. The channel filled with avidin-FITC was incubated for another 1 hr at RT to allow 
reconfiguration of the adsorbed molecules in forming strong attachment on PDMS. Free 
avidin-FITC in bulk solution was removed by extensive washing with PBSA. Pre-wash 
and post-wash images of the microchannel were captured with epifluorescence 
microscope (Nikon, JP) equipped with a 100 W mercury lamp. 
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4.2.3 Immobilization test using fibrinogen as example protein 
Fibrinogen was chosen as a test protein to evaluate the effectiveness of my 
immobilization strategy (see 4.2.1). It was labeled simultaneously with biotin for 
immobilization purpose, and with fluorescein for detection purpose. The labeling 
procedure and the protocol for protein immobilization in PDMS microchannel are 
described in Appendix 3.  I also quantified the immobilized biotin-fibrinogen-FITC (see 
Appendix  4 for quantification method).  
4.3  Example biomolecular binding systems for measuring 
dissociation kinetics in microchannel 
A monoclonal antibody-antigen system and an enzyme-inhibitor system were 
selected as example binding systems (4.3.1 & 4.3.2). See Appendix 5 for binding system 
selection criteria. 
4.3.1  Monoclonal antibody-antigen system:  insulin & anti-insulin IgG 
Insulin is an important hormone responsible for regulating blood glucose. It is a 
small size protein (MW 5.8 kDa) which can be labeled with amine-reactive fluorescein. 
Insulin was ordered from Sigma (I2643), monoclonal anti-insulin IgG (MW 150 kDa) 
was from R&D system (MAb1417, clone 182410).  
Equilibrium dissociation constant KD was determined at ~ 2 μM from a separation 
assay (done by Darren Tan). Anti-insulin IgG was incubated with insulin-FITC at RT 
until the state of equilibrium was reached. The IgG-bound fraction of insulin-FITC was 
then separated from the free fraction by ultrafiltration (Vivaspin 500, 50 kDa MWCO, 
from Sartorious). The ultrafiltration was carried out under 20 oC to avoid disturbance of 
the established equilibrium. The amount of bound insulin-FITC can be determined. 
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=                                                           (4.1) 
where eχ is the fraction of insulin-FITC bound to the antibody.  
4.3.2  Enzyme-inhibitor system:  aprotinin & trypsinogen   
Considering the high expenses of antibody-antigen system, I found a low cost 
enzyme-inhibitor system that meets the requirement introduced in Appendix 5.  
Aprotinin, a small globular protein (MW 6.5  kDa) with 58 amino acid residues, is 
a competitive serine protease inhibitor. It is also known as bovine pancreatic trypsin 
inhibitor (BPTI). Aprotinin has an unusually high affinity (KD ~ 0.06 pM, pH 8.0) to 
trypsin. In contrast, it forms a 1:1 association complex with trypsinogen (MW 23.7  kDa), 
the proenzyme of trypsin, with a reported dissociation constant KD ~ 1.8 μM under pH 
8.0 [51, 52]. The huge difference in affinity for aprotinin between trypsinogen and trypsin 
was explained by the fact that in trypsinogen, the specific binding site is incompletely 
developed [52].  So aprotinin from bovine lung (10820, Fluka) and trypsinogen from 
bovine pancreas (T1143, Sigma) were used.  Sodium bicarbonate buffer (pH 8.0) was 
selected as storage and reaction buffer as this system is sensitive to pH [52, 53].   
However, due the problems brought about by this enzyme-inhibitor system during 
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4.3.3  Preparation of proteins for immobilization and displacement assay 
4.3.3.1  Labeling of ligand protein with fluorescein 
The protein ligands (insulin, aprotinin) were labeled with amine reactive 
fluorescein under the conditions listed in Table 4.1. Insulin was labeled by Darren Tan. 
The concentration of labeled ligand was measured using BCA assay (BCATM 
Protein Assay kit, Pierce). Degree of labeling was determined by measuring the 
absorbance of fluorescein at its excitation wavelength 494 nm (Table 4.2). The average 
number of dye molecules per protein molecule can be calculated using Eqn 4.2 derived 




protein ε= ×                                                                           (4.2) 
where DOL represents degree of labeling, A494 is the absorbance of protein-dye at 494 
nm, εdye is the extinction coefficient of dye at 494 nm, and [protein] is the molar 
concentration of the protein.  
Table 4.1  Experimental conditions for conjugation of fluorescein to ligand proteins 
Protein Name Insulin Aprotinin 
Protein concentration 
in reaction mixture 
10 mg/mL 10 mg/mL 
Fluorescein 
fluorescein-X succinimidyl ester (F6129, Molecular Probe) 
dissolved in DMSO 
Molar ratio of  
protein: fluorescein 
1: 5 1: 5 
Reaction buffer 
0.1 M sodium bicarbonate 
buffer (pH 8.3) 
0.1 M sodium bicarbonate 
buffer (pH 8.3) 
Incubation condition Incubation at RT for 1 hr. 
Incubation with shaking at RT 
for 1 hr, followed by overnight 
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incubation at 4oC in the dark. 
Purification 
Ultrafiltration with 
VIVASPIN 500 (MWCO 3 
kDa) 
Ultrafiltration with VIVASPIN 
20 (MWCO 3 kDa) 
 
Table 4.2  Degree of labeling with fluorescein. 
Protein Name Insulin  Aprotinin 
Degree of labeling  not determined 1.56  FITC /protein 
 
4.3.3.2  Labeling of receptor protein with biotin 
The receptor proteins (anti-insulin IgG, trypsinogen) were labeled with amine 
reactive biotin under the conditions listed in Table 4.3. The concentration of labeled 
receptor protein was measured using BCA assay (BCATM Protein Assay kit, Pierce). 
Biotin incorporation was estimated using HABA-avidin assay (EZTM biotin-quantification 
kit, Pierce) (Table 4.4). The absorbance of avidin-HABA complex at 500 nm decreases in 
proportion to the concentration of biotin as a result of displacement of HABA dye from 
avidin due to the higher affinity of avidin for biotin. The change in absorbance of HABA-
avidin premix after adding biotin-protein sample is correlated with the amount of biotin 
in the sample.  
Table 4.3  Experimental conditions for conjugation of biotin to receptor proteins 
Protein Name Anti-insulin IgG Trypsinogen 
Protein concentration 
in reaction mixture 
1 mg/mL 10 mg/mL 
Biotin NHS-PEO-Biotin (21329, Pierce) dissolved in DI water 
Molar ratio of  
protein: biotin 
1:10 1: 5 
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Reaction buffer PBSA (pH 7.3) 
10 mM sodium bicarbonate 
buffer (pH 8.0) 
Incubation condition 
Incubation with shaking 
under RT for 1 hr, 
followed by 2 hrs 
incubation at 4oC in the 
dark. 
Incubation under RT for 1 hr 
with shaking, followed by 2 hrs 
incubation at 4oC in the dark. 
Purification 
Ultrafiltration with 
VIVASPIN 500 (MWCO 
50 kDa)  
Ultrafiltration with VIVASPIN 
20 (MWCO 10 kDa) 
 
Table 4.4  Biotinylation degree 
Protein Name Anti-insulin IgG Trypsinogen 
Degree of labeling  
Not determined due to limited 
sensitivity of HABA-avidin assay in 
characterizing highly diluted IgG 
solution. 
2.37  biotin /protein
 
 
4.4  Flow-injection analysis (FIA) system setup 
The dissociation kinetics study was carried out with a flow-injection analysis 
(FIA) system as shown in Figure 4.4 & 4.5 (see Appendix 6 for detail). A PDMS flow 
cell was fabricated in order to reduce the dispersion effect and protein adsorption along 
the flow path (also described in Appendix 6). Detection performance of the FIA system is 
evaluated in Appendix 7. 
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PDMS flow cell 
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Chapter 5  Experiment Results and Discussion 
5.1  Protein Immobilization in microchannel 
5.1.1  Verification of avidin coating in microchannel 
Figure 5.1 presents the epi-fluorescence images of negative control (channel 
prepared by flowing through PBSA buffer only (Figure 5.1A)) and subject (channel 
coated with 100 nM (Figure 5.1B) or 1 μM avidin-FITC (Figure 5.1C)). Pre-wash images 
reflect the fluorescence signal from the channel filled with bulk solution, whereas post-
wash images show the fluorescence signal resulting from only the fluorescent molecules 
immobilized on the channel walls. Significant fluorescence intensity was observed in the 
post-wash images of subject channels (Figure 5.1B & C 2nd row), suggesting that avidin-
FITC had been adsorbed on the PDMS walls. Even an 8-hour washing step did not lead 
to a significant drop in fluorescence (Figure 5.1B & C 3rd row), indicating that 
irreversible adsorption of avidin had occurred in subject channels. 
In addition, much stronger fluorescence signal in post-wash image was detected 
for the channel prepared with 1 μM avidin-FITC by comparing Figure 5.1B and C. This 
result may be explained by the fact that using higher concentration of avidin-FITC results 
in many more layers of avidin molecules depositing on PDMS surface due to the higher 
flux of protein near the surface during the flow-induced coating process.  
As mentioned in 4.2.1, avidin layer adsorbed on PDMS wall plays an important 
role in both capturing biotin-conjugated protein and blocking nonspecific binding, hence 
it is desirable to achieve a complete surface coverage of avidin for efficient protein 
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immobilization.  Based on these considerations, 1 μM avidin was used to coat PDMS 
microchannel in my experimental protocol for protein immobilization. 
 
                      A                                            B                                             C 
















post 8-hr wash 
Figure 5.1  Verification of avidin-FITC coating in PDMS microchannel through epi-
fluorescence images of (A) Negative control (channel flowed through with PBSA buffer 
only). (B) Channel coated with 100 nM avidin-FITC. (C) Channel coated with 1 μM 
avidin-FITC. The top panels show the pre-wash images, the middle and bottom panels 
show respectively the post-wash images captured after 1 hour and 8 hours washing with 
PBSA.  
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5.1.2  Immobilization of fibrinogen as test protein 
5.1.2.1  Immobilization of fibrinogen 
Fibrinogen labeled with both biotin and fluorescein (see Appendix 3 for labeling 
procedure) was employed in subject channel to evaluate my immobilization strategy, 
while fibrinogen labeled with FITC only (see Appendix 3) was used for negative control 
in order to test nonspecific adsorption of the protein onto the PDMS surface.  Epi-
fluorescence images were captured.  
As shown in Figure 5.2, for pre-wash image, there was no significant difference 
between the subject and control in terms of fluorescence intensity. It is because the two 
lanes were filled with either biotin-fibrinogen-FITC or fibrinogen-FITC which has the 
same concentration and similar fluorescein labeling degree. And it was the fluorescent 
molecules present in the bulk solution rather than those immobilized on the channel wall 
that contributed mainly to the pre-wash images.  
In contrast, for post-wash image, much higher fluorescence signal was observed 
in subject channel as compared with that in control, implying that biotin-fibrinogen-FITC 
was immobilized to the channel wall via the specific binding between biotin and avidin 
rather than through nonspecific adsorption. The underlying mechanism responsible for 
this difference is schematically illustrated in Figure 5.2 (3rd row). 
Another conclusion I can draw from the post-wash image of the control lane 
(Figure 5.2B 2nd row) is that nonspecific adsorption of fibrinogen on PDMS was 
efficiently suppressed by my proposed blocking strategy, which depended on a combined 
effect of the avidin coating and a customized blocking buffer (see 4.2.1).  Consequently 
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the low level of nonspecific adsorption of fibrinogen contributed to an enhanced signal to 
noise ratio (specific vs. nonspecific immobilization).   
 



















Figure 5.2  Immobilization of biotinylated fibrinogen in avidin-coated PDMS 
microchannel. Epi-fluorescence images of (A)Subject channel prepared by introducing 
fibrinogen labeled with both biotin and FITC. (B) Control channel (for testing 
nonspecific adsorption) prepared by introducing fibrinogen labeled with FITC only.  The 
top and middle panels give pre-wash and post-wash images respectively; the bottom 
panels schematically outline the strategy used to immobilize biotin-fibrinogen-FITC on 
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5.1.2.2  Quantification of immobilized fibrinogen 
An indirect method was adopted to quantify the amount of biotin-fibrinogen-FITC 
that was immobilized in a microchannel by measuring the difference between the input 
protein and the output protein upon immobilization (see Appendix 4).  
The concentration of input and output biotin-fibrinogen-FITC was determined 
from the standard curve (shown in Appendix 4).  The amount of immobilized protein was 
calculated accordingly in Table 5.1. 
Table 5.1  Experimental quantification result for biotin-fibrinogen-FITC 









Immobilized amount  
(pmole/channel) 
Average surface density C0
(pmole/cm2) 
328.5 80 303.5 80 
= C1V1-C2V2 
= (C1-C2) * V1 
= 2.0 
= Immobilized amount / 
surface area per channel 
=  10.58 
 
C1 , V1 -  Concentration and volume of input biotin-fibrinogen-FITC 
C2 , V2 -  Concentration and volume of output biotin-fibrinogen-FITC 
Surface area of a single microchannel  S = 2 * (240 μm + 30 μm) * 3.5 cm = 0.189 cm2
 
The average surface density of fibrinogen C0 could be regarded as the initial 
surface density of a given receptor immobilized in the microchannel because the same 
immobilization protocol is used (Appendix 3). Accordingly, surface density of the bound 
fluorescent ligand is C0 for a monovalent binding system, and it is 2C0 for bivalent 
system such as antigen-antibody (IgG) system. C0 was plugged into the theoretical model 
to generate a series of simulation curves (see 3.4).  
The experimental quantification result (2.0 pmole in Table 5.1) is consistent with 
the theoretical value (2.26 pmole in Appendix 4), which ensures that a reasonable 
estimation of the immobilized protein was obtained from this experiment.  
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5.1.3  Immobilization of insulin - antibody system 
One of the model binding systems I selected was insulin and monoclonal insulin 
antibody (see 4.3.1). Biotinylated anti-insulin IgG, the receptor protein of this system, 
was immobilized using the protocol introduced in Appendix 3. (The specific binding 
between avidin and biotinylated anti-insulin IgG was confirmed in advance by a solution 
phase binding assay performed with ultrafiltration (Appendix 11).) In order to check the 
efficiency of immobilization, insulin-FITC (in blocking buffer) was then injected into the 
microchannel as described in step 3 of the displacement assay protocol (see Appendix 8). 
In a negative control experiment, all the steps were identical, except that the step of 
introducing biotinylated insulin-antibody was omitted.  
After washing with buffer to remove the free insulin-FITC in bulk solution, epi-
fluorescence images of the channel were captured (Figure 5.3).  There is a distinguishable 
fluorescence contrast between the post-wash image of the subject and that of the negative 
control (Figure 5.3A, B). This suggests that insulin-FITC specifically bound to the 
immobilized anti-insulin IgG in the subject microchannel and therefore indirectly 
confirmed the success of the immobilization step for biotinylated anti-insulin IgG. 
Also, a comparison was made in Figure 5.4 for negative controls performed in the 
absence and presence of the blocking buffer when preparing insulin-FITC, which clearly 
demonstrates the significance of the blocking buffer in preventing nonspecific adsorption 
of insulin-FITC.  
However, it is worth noting that the fluorescence intensity resulting from the 
bound insulin-FITC is relatively weak (Figure 5.3A), compared to that of the biotin-
fibrinogen-FITC (Figure 5.2A post-wash image). This difference can be accounted for by 
the fact that fibrinogen has a much larger size (350 kDa) than insulin (5.8 kDa). Due to 
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the numerous primary amine-containing residues on a large protein, several fold more 
fluorescent tags could have been attached to each fibrinogen molecule than to each 
insulin during the labeling process. 










Figure 5.3  Immobilization of biotinylated anti-insulin IgG in avidin-coated 
microchannel.  Epi-fluorescence images of (A)Subject channel prepared by introducing 
biotinylated anti-insulin IgG followed by insulin-FITC. (B) Control channel (for testing 
nonspecific adsorption) prepared by introducing insulin-FITC only.  The top panels show 
the post-wash images; the bottom panels schematically outline the strategy used to 
immobilize biotinylated anti-insulin IgG on PDMS surface.   
 





Figure 5.4  Comparison of the post-wash images from negative controls prepared with 
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5.2  Flow-based displacement assay in microchannel 
5.2.1  Displacement assay with insulin-antibody system 
The flow-based displacement assay was carried out using the protocol described 
in Appendix 8. The negative control experiment shared all the identical steps with the 
subject, except that the step of flowing biotinylated insulin-antibody was skipped.  
PMT monitoring was started immediately when injecting washing buffer into the 
microchannel prefilled with insulin-FITC. And washing was stopped as soon as the 
measured signal returned to baseline.  A typical time trace of buffer washing is presented 
in Figure 5.5.  (PMT calibration curve for insulin-FITC is given in Appendix 15) 
Figure 5.6 shows the recorded time traces of the displacement step induced by 
continuously introducing unlabeled insulin with a flowrate of 1 μL/min.  During the 30-
minute monitoring, no significant difference was observed between the subject and the 
control, so it appears that displacement may not have occurred effectively. Considering 
the time delay in fluorescence measurement, which was ~ 7 minutes in this experiment 
( (Vinlet+Voutlet)/flow rate), the slight drop of signal from the beginning could hardly have 
resulted from displacement. Rather, it was possibly caused by the fluorescent bulk 
solution trapped in the outlet pocket before the introduction of unlabeled insulin.  
Further, the above displacement result was confirmed by epi-fluorescence images 
(Figure 5.7). Post-wash image was captured after removing the free insulin-FITC by 
running buffer, and before carrying out displacement. Post-displacement image was 
captured after displacement by unlabeled insulin. The image from the subject experiment 
(Figure 5.7A) reveals that although the fluorescence intensity slightly decreased after 
displacement, the post-displacement image still remains bright, which implies that 
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considerable amount of insulin-FITC was still bound to the immobilized anti-insulin IgG 
without being displaced by the insulin present in the bulk flow.  
The following factors could have been responsible for the failure to obtain a 
detectable displacement signal. 
1. Concentration dependence of displacement 
In my theoretical model (see 3.1), an assumption was made that displacement will 
always happen as nonfluorescent ligand is constantly introduced, and hence the 
concentration dependence of the displacement efficiency was ignored. This may not 
reflect the real situation.  In order to rule out the influence of insulin concentration on the 
displacement result, I increased the flowrate to 10 μL/min in displacement step with the 
purpose to increase the flux and therefore the concentration of insulin near the antibody-
bound surface. However, this adjustment did not lead to any improvement of the 
displacement signal (shown in Figure 5.8). 
2. Kinetic rate constant below the detection limit 
Although the equilibrium dissociation constant of this antigen-antibody system 
was estimated to be in μM range (see 4.3.1), the dissociation phase could be relatively 
slow so as to generate the displacement signal whose magnitude is below the detection 
limit of the current FIA system (10 nM FITC). In this case, the signal might be enhanced 
by increasing the length of channel in future design according to my simulation result 
shown in 3.4 (see 6.2 for recommendation).  
3. Mass transport limitation in displacement assay associated with big molecules 
Another important issue that may account for the lack of observable signal is the 
mass transport limitation of kinetic analysis [4].  As reported earlier, ligand binding to 
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immobilized receptor is strongly influenced by mass transport [9, 54, 55]. Especially for 
big ligands, such as proteins, the dissociation process is retarded to a great extent by slow 
diffusion and rebinding of the dissociated ligands. Consequently, the apparent 
dissociation rate constant might be considerably lower than the intrinsic rate constant. My 
result suggests that insulin, as a small protein, still might be too big to be displaced from 
the immobilized antibody, and a proposed mechanism is explained as follows.  
Being a relatively large molecule, dissociated insulin-FITC would diffuse too 
slowly for it to enter the bulk flow before rebinding occurs. Hydrodynamic interactions 
will result in slower diffusion near a surface or other macromolecules. Similarly, 
unlabeled insulin from the bulk flow would diffuse too slowly for it to reach the binding 
site before rebinding of the insulin-FITC. Together, these phenomena would have led to 
the inefficient ligand displacement. Without a detectable displacement signal, 






















Figure 5.5  Typical time trace of buffer washing of microchannel prefilled with      
insulin-FITC (700 nM). (Light source:  blue LED; PMT internal gate time = 2 sec; 
flowrate=1 μL/min). 
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Figure 5.6  Time trace of the eluting displaced insulin-FITC induced by 
constantly introducing unlabeled insulin (flowrate = 1 μL/min )  into (A) Subject 
channel (avidin coating →immobilization of biotinylated insulin mAb → insulin-
FITC binding → washing); (B) Control channel (avidin coating → flowing 
through insulin-FITC → washing).  
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Figure 5.7  Verification of displacement efficiency through post-wash images (top panels) 
and post-displacement images (bottom panels) of (A) Subject channel; (B) Control 




















Figure 5.8  Time trace of the eluting displaced insulin-FITC induced by constantly 
introducing unlabeled insulin (flowrate = 10 μL/min ) into subject channel (refer to 
Figure 5.6 for description). 
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Chapter 6  Conclusion and Recommendation 
6.1  Conclusions 
I have presented a theoretical and experimental study towards the realization of 
kinetic rate measurement (koff) based on flow displacement technique in a PDMS 
microfluidic device. The main conclusions drawn from this study may be summarized as 
follows.  
I developed a theoretical two-dimensional mass balance model describing the 
transient convection, diffusion and dissociation of the labeled ligand displaced from the 
immobilized receptors in a microchannel. The accuracy of the model was improved by 
taking into account the time delay in displacement (displacement does not occur until the 
flow front of unlabeled ligand reaches the particular labeled ligand within the channel). 
The model was solved analytically and numerically under the same set of assumptions 
and boundary conditions. There was a good agreement between the analytical and the 
numerical solutions. The correctness of the analytical solution was verified by checking 
the mass balance for the labeled ligand.  
Furthermore, the simulation results of the eluting time trace of labeled ligand 
were derived based on the model, which predicts that magnitude of the eluting 
fluorescence signal increases with the decrease in flowrate during displacement and the 
increase in the length of channel. However, considering the extended duration of flow 
experiment under a slow flow rate, and more receptor consumption and serious 
dispersion brought about by a longer channel, an appropriate tradeoff has to be 
determined. This model served as the guidelines when designing my flow displacement 
experiment. With the detection instrument currently available in our lab, the 
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microchannel design (3.5 cm x 240 μm x 30 μm) can satisfy the needs of measuring 
dissociation kinetic rates ranging from 0.1-0.001 sec-1.  
Next, a series of experiments were carried out in a PDMS microchannel. Above 
all, the receptor protein was to be immobilized indirectly onto PDMS channel surface 
exploiting the high affinity binding of biotin to avidin. Biotin with a long spacer link was 
selected for labeling the receptor protein in order to ensure accessibility of binding sites. 
Fluorescein-tagged avidin was used to confirm the robustness of avidin coating step.  The 
immobilization protocol was established by using an example protein, fibrinogen, and the 
result demonstrated the feasibility of my protein immobilization strategy. In addition, the 
blocking buffer proved to be essential and effective in suppressing nonspecific adsorption 
of protein in PDMS microchannel. Immobilized fibrinogen in microchannel was then 
experimentally quantified, the result of which was found to be consistent with the 
theoretical estimation.  
Model binding systems were selected including an antigen-antibody system 
(insulin & anti-insulin IgG) and an enzyme-inhibitor (aprotinin & trypsinogen) system. 
Anti-insulin IgG was successfully immobilized with my established protocol. Insulin 
labeled with fluorescein was used to indirectly confirm the immobilization result. 
Meanwhile it also proved the specific binding between insulin-FITC and insulin-antibody. 
However, the same immobilization protocol did not work well for the aprotinin-
trypsinogen system, so no further binding study was conducted with this enzyme-
inhibitor system. 
A PDMS flow cell was built to connect a microchannel with a fiber optic 
fluorescence probe for real-time monitoring of the eluting fluorescent molecules at 
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channel outlet. Experiments demonstrated that my fabricated PDMS flow cell 
outperformed the commercial one with a remarkably reduced dispersion effect, which is 
extremely important in minimizing signal distortion during real-time monitoring of the 
eluting time trace, while exhibiting acceptable detection sensitivity (10 nM FITC) and 
good measurement linearity.  
Flow-based displacement assay was performed in microchannel with the insulin-
antibody system, and various flowrates were tested. However, no detectable signal was 
observed at the channel outlet. One probable reason could be the mass transport 
limitation associated with big protein ligands, suggesting that insulin-FITC may be too 
large to be displaced from the binding site by unlabeled insulin. This method might be 
particularly applicable to those binding systems involving small ligands (see 6.2 for 
recommendation).  
With numerous inherent advantages associated with this proposed microfluidic 
device, such as low cost, easy setup, low consumption of reagent, and the potential for 
expanded applications, I believe that it is a promising substitute for stopped-flow or 
biosensor based device (BIAcore).  
6.2  Directions for further study 
The theoretical displacement model can be further developed by incorporating 
axial dispersion and substituting parabolic flow profile for uniform flow velocity, which 
are expected to contribute more accuracy to the model.  
Regarding the undetectable signal of eluting insulin-FITC, one possible reason is 
that the weak eluting signal was below the detection limit (see 5.2.1). This hypothesis 
may be proved by the use of multiple channel design to raise the signal, but the price paid 
 63
Chapter 6 Conclusion and Recommendation 
for this improvement is increased receptor protein needed for immobilization as well as 
the ligand.  
Another possibility is that this method might be suitable for studying small ligand 
- binding systems so as to avoid mass transport limitation during displacement. Steroid 
hormone and receptors could be a potential candidate for demonstrating the application of 
this approach. However, the intimidating cost is stopping me from working with such 
system. So I suggest trying HABA dye complexed with avidin, which can readily be 
displaced by biotin (as occurs in routine biotin quantification assay) by means of 
absorbance detection.  
I realize that one big hurdle for this project is the high cost of commercial 
antibodies or receptors, which poses difficulty in testing various experimental designs. 
Molecularly imprinted polymers bearing the mimics of antibody or receptor’s binding 
sites could offer a low cost alternative [56, 57]. The principle underlying this technique is 
using target ligand as the template to direct the assembly of the binding sites, resulting in 
a functionalized polymer. A microchannel coated with this polymer is capable of 
recognizing and specifically binding to the target ligand.  
As I mentioned earlier, sensitivity of the FIA system depends on reduced 
dispersion. Although using the PDMS flow cell has lowered the dispersion to a large 
extent (see Appendix 7), it still cannot be completely eliminated mainly due to the non-
negligible volume of the current inlet/outlet design. I notice that it is the dispersion 
resulting from the channel outlet, rather than inlet, that mainly influences the eluting time 
trace of dissociated labeled ligand, and therefore is the main concern in future device 
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design. Several new designs are recommended as follows with the potential to minimize 
the outlet effect.  
 








PDMS flow cell outlet terminaleffective test length 
Figure 6.1  Recommended system designs with the potential to minimize 
dispersion resulting from a large outlet. 
                              
z Design I  (Figure 6.1A) 
In this design, the outlet terminal of a straight channel directly connects to a 
horizontal capillary (or thin PEEK tubing) to obviate the need for a huge punched outlet. 
PDMS flow cell is used to fix the fiber optic fluorescence probe. 
z Design II (Figure 6.1B) 
An alternative design is based on a Z-shaped microchannel (recommended by 
Darren Tan). A long horizontal segment is the effective channel where the receptor-
ligand binding is to be studied. Light is coupled into and guided through the channel 
when the fiber optic probe is directly facing the end of the short vertical segment of the 
channel. This design offers an advantage over Design I to circumvent the need for 
extended tubing and external flow cell, but the probe window is required to be aligned 
properly with the vertical segment.  
z Design III 
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In the above designs, microchannels have to be interfaced with the macroscale 
optic probe, whose detection limit is largely degraded by the minute detection volume 
associated with microfluidics. Besides that, another limitation is the inability to monitor 
exactly at channel outlet, a requirement prescribed by my method. Thus, to further 
improve the detection sensitivity and precision of observation location, I suggest 
designing an optical fiber interrogated microchannel [58]. By incorporating an optical 
fiber into the microchannel to probe a fabricated detection area exactly at channel outlet, 
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Appendix 1   
Microfluidic device 
z Background 
Inspired by the successful experience of microelectronics, Micro Total Analysis System 
(μTAS) or Lab-on-Chip (LOC) has just been around since the introduction of this concept by 
Manz and coworkers in the late 1980s [59]. The appearance of it attributes to the current trend in 
many fields to shift conventional lab-centered chemical analysis closer to customer-end [59].  
As the heart of uTAS, microfluidic device refers to miniaturized systems which transport 
and/or process minute amount of fluid typically measured in micro- and nanoliters. According to 
Nam-Trung and Steven T. Wereley [60], only the microchannel where the fluid is 
transported/processed needs to be miniaturized, while the surrounding instruments do not 
necessarily need so. 
Many benefits brought about by microfluidic system provide the driving force behind the 
vigorous development in this new research discipline. Firstly, there will be a significant cost 
reduction due to the application of microfluidic channel which consumes only microliters of 
samples and reagent. It is especially meaningful when only limited amount of samples or reagents 
is available.  Accordingly, reduction in chemical analysis product avoids excess generation of 
harmful substance.  Secondly, microfabrication technique ensures well-tested designs to be 
reproduced for many times with high fidelity. Plus the usage of the commonly accepted polymer 
material like PDMS, all these factors promise the mass production potential of low cost, 
disposable diagnostic device, i.e. commercial value of microfluidic device.   Thirdly, microfluidic 
device offers high-throughput advantage in the sense that it allows hundreds or even thousands of 
experiments to be run in parallel which provides cost-effective means for drug screening.  
Another prominent characteristic of microfluidic device is the efficient mass transfer resulted 
from its small dimension, leading to dramatic reduction of analysis time. For instance, traditional 
ELISA performed in microwell plate usually takes more than 24 hours; whereas it can be 
accomplished in as short as 2 hours in microchannel format [11]. Furthermore, it makes possible 
some studies that are difficult to carry out with large-scale device. For example, a microfluidic 
channel of size (~10 μm), flow velocity (0.1 cm/s) and elasticity similar to in vivo capillaries can 
be used as research and diagnostic device to obtain more accurate physiological information [45].  
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Despite these attractive sides of microfluidic device, we have to understand it is still in an 
early stage of its existence and left with many issues pending to be addressed.  Major problems 
are directly related to the small dimension of microchannel, such as the challenges in detection, 
susceptibility to particle or cell blockage and more sensitivity to substance adsorption on the 
surface [45].  Another prominent issue is interconnection of microfluidic chip with the 
surrounding macroworld of instrumentation [59]. Some of the problems mentioned above were 
also encountered in my project.  
Over the past ten years, microfluidic device as a multidisciplinary topic, have gained 
rapidly increasing attention from both scientific and industrial community which made possible 
simultaneous advances on many fronts [60]. Next, I will cite a few examples to demonstrate how 
microfluidics is revolutionizing the way things are done in biomedical field.  
z Biomedical applications 
As illustrated in a comprehensive review presented by Manz’s group, microfluidic 
devices have their applications spanning the gene, protein and cell level [61].  
At the gene level, many methods were developed for DNA separation and analysis. 
Doyle et al. reported using self-assembled magnetic matrices for DNA separation based on many 
advantages of paramagnetic particles [62]. Medintz et al. employed capillary array 
electrophoresis (CAE) microchannel plate device to achieve high-speed genotyping [63].  Besides, 
microfluidic chips for polymerase chain reaction (PCR) [64, 65] and DNA sequencing were 
created as well [66].  
Within the context of protein analysis, diversified microfluidic systems have been 
proposed targeting proteolytic digestion [67], protein or peptide separation. For instance, a glass 
microfluidic chip was devised by Ramsey et al. for high-efficiency, two-dimensional separations 
of tryptic digests. The first dimension separation was based on micellar electrokinetic 
chromatography, while the second used capillary electrophoresis [68]. These applications have 
provided value to proteomics research. As an example, Li et al. introduced a novel integrated and 
modular microdevice equipped with a protein autosampler, an affinity-selection preconcentration 
channel and a separation unit that allows interfacing with nanoelectrospray mass spectrometry 
[69]. 
Furthermore, this research area sees an increased interest in probing more sophisticated 
biological systems like living cells [70]. As a result, various applications have been achieved with 
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microfluidic devices including cell culture [71], cell trapping and separation [72], cell treatment 
(cell lysis, gene transfection and cell fusion) and other cellular studies [70].  
It is worth mentioning that the potential practical applications in clinical diagnostics 
promise the great commercial value of microfluidic chip. Detection of multiple diagnostic 
markers from a trace of blood was demonstrated with a disposable healthcare chip [73]. Lander’s 
group discussed the possible realization of uTAS for Duchenne muscular dystrophy (DMD) 
diagnosis [74]. With the active participation of the industry, a colorful microfluidics market is to 
be expected.  
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Appendix 2  
Simulation of the time trace of displaced labeled ligand for longer channel 
design 
z Simulation result for koff = 0.01 s-1 (Q = 1 μL/min) 




























































































Figure A2.1  Simulation of the time trace of displaced labeled ligand for various channel 
lengths (L=3.5 cm, 15 cm and 30 cm) under koff  0.01 s-1. (A) Dimensionless vs. 
dimensionless time. (B) Dimensional  vs. dimensionless time. Solid line: measured 








z Simulation result for koff = 0.001 s-1 (Q = 1 μL/min) 

























































































Figure A2.2  Simulation of the time trace of displaced labeled ligand for various 
channel lengths (L=3.5 cm, 15 cm and 30 cm) under koff  0.001 s-1. (A) 
Dimensionless  vs. dimensionless time. (B) Dimensional  vs. 







Appendix 3  
Immobilization test using fibrinogen as example protein 
z Preparation of fibrinogen labeled with both biotin and fluorescein 
To prepare fibrinogen for the immobilization experiment, it needs to be conjugated with 
biotin. On the other hand, for detection purpose, I want fibrinogen to be labeled with fluorescein. 
Since both biotin and fluorescein are amine-reactive succinimide ester, they will be conjugated to 
protein molecule with the same mechanism by targeting primary amine of lysine residues and the 
N-terminus of each polypeptide. Hence, I combined the two labeling reactions so that biotin and 
fluorescein competed for –NH2 groups in the same reaction mixture. Labeling was done with the 
following procedure: 
1. Prepare a fibrinogen solution of 10 mg/ml in 0.1 M sodium bicarbonate buffer (pH 8.3). 
2. Dissolve biotin and fluorescein ester separately in DMSO (10 mg/mL). 
3. Add biotin and fluorescein solution to the fibrinogen at a ratio of biotin: FITC: fibrinogen = 
5:5:1. 
4. Incubate the reaction mixture at RT for 1 hr with continuous shaking, and incubate under 4oC 
for another 2 hrs. 
5. Remove uncoupled biotin and fluorescein by ultrafiltration (VIVASPIN 20 MWCO 100 kDa , 
from Sartorious) with the following experimental conditions: fixed angle, spin force 12000 g, 
repeat 3 times. For storage purpose, buffer exchange was done during each cycle of 
ultrafiltration by topping up retentate with PBSA.  
6. Determine the labeled fibrinogen concentration by measuring absorbance at 280 nm and 494 
nm. 
Meanwhile, I also prepared fibrinogen tagged with fluorescein only (FITC: fibrinogen = 
5:1) as a control in order to test nonspecific adsorption of the protein.  
z Protocol for protein immobilization in PDMS microchannel  
In order to rule out the possibility of nonspecific protein adsorption on PDMS or avidin 
layer, I compared a subject (using biotin-fibrinogen-FITC) with a negative control (using 




1. Coat subject and control channel with 1 μM avidin (5 μL/min) for 1 hr. Incubate for another 1 
hr at RT, followed by washing with PBSA (10 μL/min) for 1 hr. 
2. Prepare 700 nM biotin-fibrinogen-FITC and 700 nM fibrinogen-FITC in blocking buffer (see 
4.2.1). Fill the channel with 700 nM biotin-fibrinogen-FITC (subject channel) or fibrinogen-FITC 
(control) (~10 μL). Then constantly flow the protein (1 μL/min) for 1 hr; incubate for another 1 hr 
at RT. It is in this step that avidin specifically captures biotin on fibrinogen, leading to its 
immobilization.  
3. Wash with PBSA (10 μL/min) for 1 hr. 
4. Check immobilization result by capturing pre-wash and post-wash fluorescence images. 
The optimal flow rate in step 2 was determined based on a simplified theoretical 
estimation using equation (A3.1), 
2 / 2diff fibt h D=                                                                                             (A3.1) 
where Dfib is the bulk diffusivity of fibrinogen ( 2.04 x 10-7  cm2/sec at 20 oC, in aqueous solution 
[75]), tdiff is the time needed for a fibrinogen molecule to diffuse to the channel bed across a 
distance of h.  
I calculated the time needed for 10% of proteins to diffuse to the bed of channel
  sec                                                                                         (A3.2) 210% / 2 5.5difft h D= =
where μm. 10% /10 (30 / 2) /10 1.5halfh H= = =
Calculated tdiff (Eqn A3.2) was compared with the residence time of fibrinogen in 
microchannel under flow rate of 10 μL/min (Eqn A3.3).  
Residence time / 3.5 / 2.3 1.52rest L v= = =  sec     <                                                    (A3.3) difft
where average velocity  3.2
30240
10 =×== A
Qv  cm/sec. 
Obviously, at such high flow velocity, fibrinogen could hardly reach the channel wall 
before leaving the channel. Therefore it is necessary to reduce the flow rate to 1 μL/min in order 
to provide sufficient time for biotin-fibrinogen to migrate from bulk solution to the channel wall 




Quantification of protein immobilized to PDMS microchannel wall 
z Experimental design 
Despite the fact that many fast and accurate assays are available for quantification of 
protein in solution, such as BCA assay or Lowry assay, standard methods have not been 
established to directly determine the amount of protein immobilized to solid surface [76]. The 
small dimension of microchannel and resulted trace amount of immobilized protein poses 
additional challenge to the quantification job. Although gravimetric methods had been attempted 
by using optical-sensor based techniques like surface plasma resonance and total internal 
reflection spectroscope or quartz-crystal microbalances, the quantification accuracy depends on 
certain unknown physical parameters such as the refractive index of a given molecule that varies 
among different proteins [76]. Some study just used typical value of refractive index to get an 
approximate estimation [77]. Besides, the sensor chip (gold coated glass for SPR) has a surface 
property different from that of PDMS, so the optical sensor method is not applicable here. 
To solve this problem, I adopted an indirect method by measuring the difference between 
input fibrinogen-FITC and output fibrinogen-FITC after immobilization. The concentration and 
volume of input fibrinogen-FITC was optimally determined based on Eqn A4.1.  
1 1 2 22 avidinC V N C V− =                                                                                    (A4.1)                          
 
C1 -  Concentration of input protein 
C2 -  Concentration of output protein 
V1 -  Volume of input protein 
V2 -  Volume of output protein 
Navidin - moles of the top layer of avidin (monolayer) adsorbed on the microchannel wall 
2Navidin - moles of biotinylated fibrinogen that bind to the top layer avidin, assuming 2 biotin      









NR avidin  represents percent of protein to be immobilized. Considering 

















VCRC avidinavidin −=−=−=−= .     
Difference between C1 and C2 is   1 2
1
2 avidinNC C C
V
Δ = − =                                                 (A4.2)         
The design principle is to maximize ΔC in order to have a detectable difference of 
fluorescence intensity measured with a microplate reader.  
After determination of optimal parameters, quantification experiment was carried out 
following the immobilization protocol in Appendix 3 except that 4 subject channels were 
prepared, and 80 μL of biotin-fibrinogen-FITC was passed through each subject channel. The 
outputs from all 4 channels were pooled, then distributed into microwell in 3 aliquots of 100 μL  
each. Measure the fluorescence of the input and output (3 replicates for both) with microplate 
reader (FLUOstar OPTIMA, BMG LABTECH, Germany). C1 and C2 were determined by 
interpolation into the standard curve of biotin-fibrinogen-FITC (Figure A4.1). The amount of 
immobilized biotin-fibrinogen-FITC is given by 
Immobilized amount = C1 x V1 – C2 x V2 ≈ (C1 – C2) x V1                          (A4.3) 
z Theoretical estimation 
Theoretical estimation of the amount of immobilized biotin-fibrinogen-FITC started from 
calculating the quantity of the adsorbed avidin in a microchannel. Since only the top layer of 
avidin may have the chance to interact with biotin, I calculated the moles of avidin to form a 







×= = =× × 3  pmole                                      (A4.4) 
where S is the surface area of a single channel (0.189 cm2),  NA is Avogadro’s number 
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Assuming that only 2 out of 4 subunits of avidin are available for biotin-binding and the 
other two binding sites are sterically blocked upon physical adsorption, moles of biotin-
fibrinogen-FITC captured by avidin is roughly estimated to be 
2 1.13 2 2.26avidinN = × =  pmole                                                                (A4.5) 
 





































Binding system selection criteria 
In order to prove the principle of this proposed method to measure dissociation kinetic 
rate, suitable model binding systems, such as antibody-antigen, receptor-ligand or enzyme-
inhibitor, need to be selected. There are a few requirements for the selected binding systems. 
1. It is preferable to be a single-valency binding system that follows the simple one-step binding 
kinetics described in 1.1. Monoclonal antibody-antigen system is also a qualified candidate as a 
monoclonal antibody (isotype of IgG) has two identical and independent binding sites for a given 
antigen with a specific binding affinity. 
2. The theoretical simulation result of the displacement curve (see 3.4) predicts that my current 
design gives a measurable range of dissociation kinetic rate constant koff from 0.1 to 0.001 sec. As 
association phase generally proceeds very fast (assume that kon ranges from 103  to 104 M-1sec-1), 
the desirable equilibrium constant KD of the binding system should be at or above 10-6 M. System 
with slow dissociation rate should be avoided as it will take much longer time to be monitored or 
need increased channel length.  
3. The ligand should be intrinsically fluorescent or can be readily labeled with fluorescein. 
Nonfluorescent form of the ligand or its nonfluorescent analog is also necessary to induce 
displacement.  
4. Small size ligand is preferred because large ones may experience the problem of mass transport 
limitation during displacement. Namely, due to the low diffusivity of big ligands, it is hard to 
displace them from their bound receptors regardless of the actual fast dissociation rate. As a result, 




Flow-injection analysis (FIA) system setup 
z FIA system arrangement 
The flow-injection analysis (FIA) system is made up of five key components (Figure 4.4 & 4.5). 
1.  Injection unit  
Syringe pump (Cole-Parmer, IL) was used to produce pressure-driven flow for the delivery of 
sample or buffer into a microchannel at a specified flow rate.  
2.  Microfluidic unit 
PDMS microfluidic device (preparation described in 4.1), as the heart of my system, provides a 
platform for all the involved biochemical reactions to take place, i.e. receptor immobilization, 
receptor-ligand binding, displacement induced dissociation of ligand.  
3.  Transport tubing (green line in Figure 4.4) 
One segment of transparent PEEK tubing (inner diameter 0.8 mm, Cole-Parmer, IL) was used to 
connect a syringe to the inlet of microchannel. Another segment was attached to channel outlet 
for the export of eluent.  
4.  Flow-through PMT detection unit 
An online detection unit allows real-time monitoring of the molecules flowing through a flow cell. 
Another advantage is the reduced risk of photobleaching due to the short dwell time of individual 
molecules in the excitation beam. It consists of several parts as described below. 
1)  Excitation light source  
For detection of fluorescein labeled molecule (λEX = 494 nm), light source can be an 
incandescent lamp followed with a monochromator or a blue light-emitting diode (LED). In 
my experiment, blue LED (Ocean Optics) was adopted as it gave higher light intensity (see 
Appendix 14 for comparison), which is a critical factor for the detection sensitivity. 
2)  Photomultiplier tube (PMT) detector  
PMT is extremely sensitive detector of light as a result of amplifying the signal of incident 




Emission wave length (λEM = 520 nm) was selected by monochromator (DongWoo Optron, 
South Korea). Filtered light signal was then fed into PMT (photon counting head, model 
H7421, Hamamatsu Corp., Japan) for amplification.  
3)  Flow cell 
A fabricated T-shaped PDMS flow cell was positioned ~3 mm from the channel outlet, fixed 
by the outlet tubing passing through the center of the cell. Details are introduced in next 
subsection. 
4)  Fiber optic fluorescence probe (blue line in Figure 4.4)  
A fiber optic fluorescence probe (FOXY 600 VIS/NIR, Ocean optics) was used to real-time 
monitor the fluorescence of eluting solution at channel outlet. It was fitted into the PDMS 
flow cell, with the probe window perpendicularly facing the exterior wall of the outlet tubing. 
This reflection probe directs incoming excitation light onto the detection area, and transmits 
outgoing emission light to the detector.   
5)  Readout device 
The electrical signal from the PMT was sent via a preamplifier and A/D convertor to a computer 
and recorded by the attached operational software M8748 (Hamamatsu). 
z Fabricated PDMS flow-cell 
The most straightforward way to interface a microfluidic chip with the light source and 
PMT detector is through a commercial fluorescence flow cell (FIA-SMA-FL, 2 mm i.d., Ocean 
Optics) with an interrogated volume of 31.4 μL (Figure A6.1). However, the minimum length of 
PEEK tubing (0.8 mm i.d.) needed to connect the microchannel outlet to the flow cell is 5 cm, 
which gives a total volume of 25.1 μL. As demonstrated in my flow experiment, this relatively 
huge volume compared with that of a microchannel (~0.3 μL) leads to not only a remarkable time 
delay of eluting signal, but also a serious dispersion and protein adsorption along the tubing and 
in turn a distortion of the measured signal (see Appendix 7).  
To solve this problem, I devised a simple PDMS flow cell through which the fiber optic 
probe can be brought much closer to the channel outlet. The T-shaped cell was formed by 
punching a vertical passage (1.08 mm i.d. ) and a horizontal one ( 2.0 mm i.d. ) through a cured 
PDMS cube (Figure A6.2A, B). It was fixed at the position (~3 mm from the channel outlet) by 
the outlet tubing passing through the vertical passage. Fiber optic fluorescence probe was inserted 
into the horizontal passage to meet the outlet tubing at the T junction. The probe window was 
positioned opposite to the external wall of the tubing (Figure A6.2C).  
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In Appendix 7, the performance of this fabricated PDMS flow cell is compared with that 





























Figure A6.2 Fabricated T-shaped PDMS flow cell (~1 x 1 x 1 cm) with a vertical 
passage 1.08 mm i.d. & a horizontal passage 2.0 mm i.d.  (A) Schematic diagram. 
(B) Photograph. (C) Side view of a microchannel showing the arrangement of 




Detection performance of the flow-injection analysis (FIA) system 
Before carrying out binding kinetics study in microchannel, the detection performance of 
the FIA system (see Appendix 6 for system setup) was evaluated in terms of the time delay and 
dispersion effect in fluorescence measurement, as well as measurement sensitivity and linearity.   
z Time delay & dispersion effect in fluorescence measurement 
I recorded the time trace of flowing insulin-FITC (600 nM) into the microchannel 
prefilled with washing buffer (PBSA, baseline signal). The PMT monitoring was started 
simultaneously with the injection of the insulin-FITC solution into the channel inlet. The flowrate 
used was 10 μL/min.  Comparison between the time trace obtained with the commercial flow cell 
and with my fabricated PDMS flow cell leads to the following observations. 
Firstly, using a commercial flow cell, the time delay of the measured fluorescence signal 
was more than 5 minutes (Figure A7.1B), corresponding to the total volume (Eqn A7.1) that the 
injected fluid had to travel before reaching the detection area.  
_ _(31.4 ) (25.1 ) (3.7 ) (3.7 )travel flow cell connection tubing inlet outletV V L V L V L V Lμ μ μ= + + + μ    (A7.1) 
In contrast, using a fabricated PDMS flow cell with the proposed arrangement of the fluorescence 
probe (see Appendix 6), the time delay was reduced to less than 1 minute (Figure A7.1 A), which 
mainly resulted from the volume of channel inlet and outlet.  
Secondly, in order to measure the concentration of the eluting fluorescent ligand at 
microchannel outlet, it is desirable to have the sample transported from the microchannel outlet 
into the flow cell in an undiluted form (i.e. no dispersion).  However, in the case of commercial 
flow cell, a considerable length of the connection tubing and a fraction of the big flow chamber 
(Figure A6.1) adversely affected the measured signal by introducing a serious dispersion effect 
and protein adsorption along the flow path (Figure A7.1B).   
As can be seen in Figure A7.1A, the dispersion effect was significantly alleviated when 
replacing the commercial flow cell with the PDMS flow cell, which might be attributed to the 
extremely shortened distance between the microchannel and the detector probe. Reduced 
dispersion is a favored quality for general flow injection analysis (FIA) system because 
dispersion has a major impact on system sensitivity (sample rates, sample concentration) [80]. 
Minimized dispersion is also a desirable advantage for kinetic analysis as it allows switching 
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rapidly from having pure buffer to analyte conditions, and vice versa [16].  Particularly in this 
project, it will prevent serious distortion of the eluting signal during real-time monitoring at 
channel outlet.  
Our group has been systematically studying the dispersion effect in PDMS microchannel  
from theory to experiments (refer to [81] for detail). 
z Fluorescence measurement linearity and detection limit  
Calibration curve (Figure A7.2) shows the measured photon count as a function of FITC 
concentration using blue LED as the excitation light source.  Signal was recorded in a static 
manner by injecting the FITC standard into the flow cell and then stopping the flow. For each 
concentration, 50 data points were obtained and averaged. The baseline offset was subtracted 
from the measured value.  
Comparing the calibration graph of the PDMS flow cell with that of the commercial flow 
cell (FIA-SMA-FL, Ocean Optics), we find that the magnitude of the measured signal was 
reduced for PDMS flow cell (Figure A7.2A and B). It is because the PDMS flow cell (0.6 μL) has 
a much smaller interrogated volume than the commercial one (31.4 μL).  However, it gave 
sensitivity (10 nM detection limit) surprisingly comparable to the commercial one and exhibited 
an even better linearity.  
To summarize, my PDMS flow cell obviously outperformed the commercial one in the 
sense that the time delay and dispersion effect was reduced remarkably while retaining an 
acceptable detection sensitivity and measurement linearity. It was demonstrated that the current 




























































Figure A7.1  Time trace of injection of insulin-FITC (600 nM) into an avidin-
coated microchannel prefilled with PBSA buffer monitored with PMT. (A) Using 
the fabricated PDMS flow cell.  (B) Using the commercial flow cell (FIA-SMA-
FL Fluorescence Flow Cell).  (Light source:  blue LED; PMT internal gate time = 






























































Figure A7.2  Calibration curve of photon count as a function of the concentration 
of FITC. (A) Using my fabricated PDMS flow cell.  (B) Using the commercial 
flow cell (FIA-SMA-FL Fluorescence Flow Cell).  (Light source:  blue LED; 





Flow-based displacement assay in microchannel 
z Introduction to displacement assay 
Displacement was originally defined as a kind of immunoassay during which the labeled 
antigen bound to immobilized antibody is replaced by the unlabeled antigen present in solution 
(Figure A8.1) [82]. It could be explained by the mechanism that unlabeled ligand blocks the 
rebinding of the dissociated labeled antigen to the antibody. Another possible mechanism is that 







Figure A8.1  Principle of displacement assay. 
 
Displacement carried out with non-flow systems, such as ELISA plate, was not very 
successful mainly due to the rebinding of dissociated labeled antigen to the immobilized antibody. 
Whereas, it has been effectively implemented in stop-flow systems, flow-injection systems and 
continuous flow systems [83].  
z Protocol for flow-based displacement assay in microchannel  
Flow-based displacement assay was performed with the following protocol.  
1. Avidin coating 
Coat a microchannel with 1 μM avidin (5 μL/min) for 1 hr. Incubate under RT for 1 hr. Then 
wash with PBSA buffer (10 μL/min) for 1 hr. 
2.  Immobilization of biotin-conjugated receptor protein (refer to Appendix 3 for detail) 
3.  Introduction of fluorescein-labeled ligand 
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Prefill the channel prepared in step 2 with 700 nM fluorescein-labeled ligand in blocking buffer, 
then flow at 1 μL/min for 1 hr. To avoid disturbing the established binding equilibrium, remove 
the free or loosely bound ligand by washing with cold PBSA buffer (1 μL/min, 15-20 min). Stop 
washing when the monitored time trace reaches baseline.  
4.  Displacement with unlabeled ligand 
Prepare 7 μM unlabeled ligand in blocking buffer. Apply it to the microchannel from step 3 for 1 
hr. Two different flow rates, 1 μL/min and 10 μL/min were tested. Flow rate of 1 μL/min was 
attempted because simulation result (in 3.4) suggests greater displacement signal occurs at lower 
flow rate, while fast flow rate 10 μL/min was examined since a higher flux of unlabeled ligand 
near the surface of channel may lead to more efficient displacement. 
To rule out the possibility of nonspecific ‘displacement’, I made a comparison between a 
subject channel (following the preceding steps 1-4) and a control (following steps 1,3,4). Only in 
the subject channel should specific binding occur between fluorescein-labeled ligand and the 
immobilized receptor.  
Step 3 and 4 were monitored with the online detection system described in 4.4 (λEX 494 
nm, λEM 520 nm). During monitoring, microfluidic chip was wrapped in aluminum foil, and the 
whole system was shielded against ambient light.  
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Appendix 9    
Matlab codes for simulation of eluting time trace 
z Matlab codes for Simulation I 
%********************************************************************** 
%  Simulation I:  
%  Eluting time trace of labeled ligand generated under various k_off 
and flow rate 
%********************************************************************** 
% Channel dimensions: W-width, L-length, H- half heigth 
% dimensionless quantities: 
% C = C'H/C0 
% t = t'u/  L
% x = x'/L 
% z = z'/H 
% 
% Pa = k_off*L/u 
% Pe = uH^2/DL 
% 
% dimensionless solution 
% C_outlet = 0, 0<=t<1 ; 
%          = Paexp[-Pa(t-1)], t>=1 
  




%C0 = 105.8 nmole/m2 
C_initial = 0.01058e-6; % unit = mmole/cm2, inital surface density of 
L* bound to immobilized R. 
L = 3.5;                % unit = cm, length of channel 
W = 240e-4;             % unit = cm, width of channel 
H = 15e-4;              % unit = cm, half height of channel          
  
k = [0.1,0.01,0.001];        % k_off = 0.1,0.01, 0.001 s-1 
Q = [1,5,10];                % Q = 1,5,10 μL/min 
u = Q*(1.0e-3)/((W*2*H)*60)    % mL.s-1/cm2=cm.s-1 
  
D = 12.9e-7;            % insulin diffusivity, unit = cm2/s 
Pe = u*H^2./(D*L) 
for i = 1:length(k) 
    k_off = k(i) 
    Pa = k(i)*L./u 
    linestyle = ['k.-';'ko-';'k^-']; % specify linestyle in each plot  
    %linestyle = ['ko-';'ks-';'kd-'];   
    markercolor = ['m';'g';'b']; 
    t=1:0.25:8;  %dimensionless time 
    %------------------- plot dimensionless C vs dimensionless t------- 
    figure(2*(i-1)+1); 
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    for j = 1: length(u) 
        C(j,:)=Pa(j)*exp((-1)*Pa(j)*(t-1));  %C_outlet = Paexp[-Pa(t-
1)], t>=1 
        
plot(t,C(j,:),linestyle(j,:),'MarkerFaceColor',markercolor(j,:),'Marker
Size',5); 
        hold on 
    end 
    xlabel ('dimensionless t') 
    ylabel ('dimensionless C outlet') 
    legend('Q = 1 μ min','Q = 5 μL/min','Q = 10 μL/min') L/
    axis([0 8 0 1]) 
    grid off 
    hold off 
     
    %------------------- plot dimensional C vs dimensionless t--------- 
    %Axis display scale should be adjusted manully 
     
    figure(2*i) 
    for j = 1: length(u) 
        % calculate dimensional C_outlet (unit=mmole/cm3=M) 
        C2(j,:)=Pa(j)*exp((-1)*Pa(j)*(t-1))*C_initial/H;  
        C2(j,:)= C2(j,:)*(1e+9);        %convert unit to nM 
        %plot(t,C2(j,:),linestyle(j,:)); 
        
plot(t,C2(j,:),linestyle(j,:),'MarkerFaceColor',markercolor(j,:),'Marke
rSize',5); 
        hold on 
    end 
    %plot detection limit = 10 nM 
    t2=0:0.2:10; 
    y = 10*ones(1,length(t2)); 
    plot(t2,y,'r-','LineWidth',2)   
    xlabel ('dimensionless t  ')
    ylabel ('C outlet (nM)') 
    legend('Q = 1 μL/min','Q = 5 μL/min','Q = 10 μL/min','detection 
limit') 
    axis([0 8 0 3000]) 
    grid off 
    hold off 
end 
  
z Matlab codes for Simulation II 
%********************************************************************** 
% Simulation II 
% fix Q = 1 μL/min, test channel length dependence of eluting time 
trace of labeled ligand 
%********************************************************************** 
% Channel dimensions: W-width, L-length, H- half heigth 
% dimensionless quantities: 
% C = C'H/C0 
% t = t'u/L 
% x = x'/L 
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% z = z'/H 
% 
% Pa = k_off*L/u 
% Pe = uH^2/DL 
% 
% dimensionless solution 
% C_outlet = 0, 0<=t<1 ; 
%          = Paexp[-Pa(t-1)], t>=1 
  
%Parameter choice for displacement assay in microchannel  
clear all 
close all 
%C0 = 105.8 nmole/m2 
C_initial = 0.01058e-6; % unit = mmole/cm2, inital surface density of 
L* bound to immobilized R. 
L = [3.5, 15, 30];      % unit = cm, length of channel 
W = 240e-4;             % unit = cm,  width of channel 
H = 15e-4;              % unit = cm,  half hight of channel 
   
k = [0.1,0.01,0.001];        % k_off = 0.1,0.01, 0.001 s-1 
Q = 1;                       % Q fixed = 1 μL/min 
u = Q*(1.0e-3)/((W*2*H)*60)   % ml.s-1/cm2=cm.s-1 
t=1:0.25:8;                  %dimensionless time 
real_unit_time = 1*L/u       % real time for unit dimensionless t 
for i = 1:length(k  )
    Pa = k(i)*L/u; 
    figure(i) 
    for j = 1: length(L) 
        % calculate dimensionless C_outlet 
        C(j,:)=Pa(j)*exp((-1)*Pa(j)*(t-1));  %C_outlet = Paexp[-Pa(t-
1)], t>=1 
        % calculate dimensional C_outlet (unit=mmole/cm3=M) 
        C2(j,:)=Pa(j)*exp((-1)*Pa(j)*(t-1))*C_initial/H;  
        C2(j,:)= C2(j,:)*(1e+9);        %convert unit to nM 
        subplot(length(L),2,2*j-1),plot(t,C(j,:))         
        xlabel ('time (dimsnless)') 
        ylabel ('C outlet (dimsnless)') 
        axis([0 8 0 1.5]) 
        grid off 
        subplot(length(L),2,2*j), plot(t,C2(j,:)) 
        hold on 
        %plot detection limit = 10 nM 
        t2=0:0.2:10; 
        y = 10*ones(1,length(t2)); 
        subplot(length(L),2,2*j), plot(t2,y,'r--','LineWidth',2) 
        hold off         
        xlabel ('time (dimsnless)') 
        ylabel ('C outlet (nM)') 
        axis([0 8 0 10000]) 
        grid off 
    end 
end  
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Appendix 10    
HPLC Profiles   
z Verification of the binding of avidin to biotinylated fibrinogen  
(Alltech Macrosphere GPC 300A) 
 
1. Injection of avidin (20 μM) 
 
2. Injection of fibrinogen-FITC (5 μM) 
 
3. 1) Mix fibrinogen-FITC (5 μM) with avidin (20 μM);  2) Run HPLC 
 
4. 1) Incubate fibrinogen-FITC (5 μM) with biotin (molar ratio of fibrinogen: biotin = 
5:1 in reaction mixture) @ RT for 1 hr;  2) Add 20 μM avidin into the reaction 
mixture from 1);  3) Run HPLC. 
 





z Checking the purity of biotinylated IgG (purified using ultrafiltration after 
labeling)  
(Alltech Macrosphere GPC 100A) 
 
1. Injection of biotin (10 mM) 
 




z HPLC profiles of trypsinogen & aprotinin  
(Alltech Macrosphere GPC 100A) 
 
1. Injection of trypsinogen (300 μM) 
 





Solution phase binding of avidin-FITC to biotinylated anti-insulin IgG  
(tested using ultrafiltration 100 kDa MWCO) 
z Experimental design - Calculation of fraction bound 
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eχ  is the fraction of L (biotinylated anti-insulin IgG) that is bound to the R (avidin) 
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i.e.  100% of biotinylated anti-insulin IgG will be bound to avidin at equilibrium under the given 
concentration. 
There are 4 biotin-binding sites on avidin. Assuming 2-4 binding sites will be occupied by biotin, 
there will be 25% - 50% avidin bound to biotinylated anti-insulin IgG at equilibrium. 
z Solution phase binding test with ultrafiltration (100KDa MWCO) 
-Experimental Procedure 
1. Prepare sample - 100 μL mixture of 100 nM avidin-FITC and 100 nM biotinylated anti-
insulin IgG in PBSA buffer. Incubate the mixture under RT for 1 hr with shaking. 
Prepare control - 100 μL of 100nM avidin-FITC only in PBSA buffer 
2. Load 100 μL sample/control into ultrafiltration cartridge (MWCO = 100 kDa). Spin @  
12000 g, 20 oC for 8 min, get filtrate and retentate fraction (vol ~ 7 μL). 














corrected) 1119 529 249 776 94 
Percentage (%) 100 47 22 69 8 
Sum of retentate 
and filtrate (%) - 69 77 
 
-Conclusion 
Fraction of avidin-FITC that was bound to biotinylated anti-insulin IgG = (1- 529/776) * 100% = 




Solution phase binding of avidin to biotinylated trypsinogen  
(tested using ultrafiltration 30 kDa MWCO) 
z Avidin recovery test for VIVASPIN 500 ultrafiltration cartridge (30 kDa 
MWCO) 
- Experimental procedure 
1) Load 100 μL 50 μM sample, spin @ 12000 g, 20 oC for 8 min, get filtrate 1. 2)Top up recovery 
fraction from 1 with buffer to 100 μL, spin again, get filtrate 2 & retentate. 3)Top up the retention 












Abs 590nm 0 1.006 0.019 0 0.871 
Percentage 
of avidin 0% 100% 1.9% 0% 86% 
- Conclusion 
After the 2nd round spin, avidin recovery rate = 86%. Therefore this ultrafiltration 
cartridge can be used for testing the binding of avidin to biotinylated trypsinogen. 
z Test of binding of avidin to biotinylated trypsinogen using VIVASPIN 500 (30 
kDa MWCO) 
-  Experimental procedure 
1) Mix 10 μM biotin-trypsinogen with an excess of avidin (50 μM), incubate under RT for 1 hr 
with shaking. 2) Load 100 μL sample, spin @ 12000 g, 20 oC for 8 min, get filtrate 1 and 
retentate fraction (vol ~ 5 μL). 3)Add 2 μL 50 μM avidin to the retentate fraction from 2, sit for 5 
min. Then top up with buffer to 100 μL, spin again, get filtrate 2. 4)Repeat step 3 to get filtrate 3-






 [biotin-typsinogen]   




















0% 100% 70.7% 2.4% 0% 0% 0% 
- Conclusion 
The majority (73.1%) of biotinylated trypsinogen passed through the membrane, indicating it was 




Immobilization of aprotinin-trypsinogen system 
The other model binding system I chose for study was an enzyme-inhibitor system, 
namely, trypsinogen and aprotinin (see 4.3.2). Biotinylated trypsinogen, as the receptor protein of 
this system, was immobilized using the protocol described in Appendix 3 except that PBSA was 
replaced by NaHCO3 buffer (pH 8.0) when preparing washing buffer and blocking buffer. The 
immobilization result was checked indirectly through the fluorescent ligand (aprotinin-FITC) that 
is supposed to bind the immobilized biotin-trypsinogen. Subject channel and negative control 
were prepared following the same procedure for insulin-antibody system (see 5.1.3), and the post-
wash images are presented as follows.                                                                             






Figure A13.1  Immobilization of biotinylated trypsinogen in avidin-coated PDMS microchannel. 
Epi-fluorescence images of (A)Subject channel prepared by introducing biotinylated trypsinogen 
followed by aprotinin-FITC. (B) Control channel (for testing nonspecific adsorption) prepared by 
introducing aprotinin-FITC only.  
 
The measured fluorescence intensity in the subject channel was indistinguishable from 
that measured in the negative control (Figure A13.1A, B), which implies that the fluorescence 
signal mainly resulted from the nonspecifically adsorbed aprotinin-FITC. Such a low signal to 
noise ratio could be due to the following two reasons. 
One reason might be that specific binding between biotin-trypsinogen and aprotinin did 
not occur either because biotin-trypsinogen did not bind to the avidin adsorbed on the channel 
wall, or because the immobilized biotin-trypsinogen had lost its binding ability to aprotinin. It 
was corroborated by a solution phase binding assay, during which biotin-trypsinogen was 
incubated with an excess of avidin, followed by ultrafiltration (membrane cutoff size 30 kDa). 
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Theoretically, biotin-trypsinogen should be captured by avidin and hence be prevented from 
passing through the membrane. However, I found unexpectedly that the majority of biotin-
trypsinogen had leaked into the filtrate (Appendix 12). Possible reasons could be the 
fragmentation of trypsinogen during the biotin-conjugation process or the compromised integrity 
of the purchased trypsinogen product (I checked this by running HPLC (Appendix 10), which 
suggested the smaller size of the intact typsinogen than it was expected to be.) 
An alternatively reason is that nonspecific adsorption of aprotinin-FITC could not have 
been suppressed with the current blocking strategy. This phenomenon is hard to understand 
because the same blocking step worked well for insulin-FITC, who has a similar molecular 
weight to aprotinin. Besides, aprotinin has a high isoelectric point (PI = 10 ), which is close to 
that of avidin (PI = 10 ). Therefore, in pH 8 buffer solution, the repulsive forces should have kept 
aprotinin from interacting with the avidin layer. To solve this problem, I had ever tried small size 
PEG (PEG 300) as the blocking reagent, but did not see any improvement (result not shown).  
Due to the trouble brought about by this enzyme-inhibitor system in the immobilization 




Determination of optimal optical parameters for PMT monitoring 
z Measured photon count (P.C.) using default incandescent light source  
(λEx 494 nm, λEm 520 nm, PDMS flow cell) 
 
Room Light Internal gate time  P.C. of PBS buffer P.C. of 1 μM FITC
1s 3948 ± 63 4901  ± 65 off 
2s 8872 ± 96 11069 ± 111 
1s 24835 ± 166 25628 ± 208 on 
2s - - 
z Measured photon count using blue LED light source (Ocean Optics) 
(λEx 494 nm, λEm 520 nm, PDMS flow cell) 
 
Room Light Internal gate time  P.C. of PBS buffer P.C. of 1 μM FITC
1s 29320 ± 187 76334 ± 286 off 
2s 58607 ± 264 152534 ± 401 
1s 40621 ± 219 94022 ± 322 on 
2s 80388 ± 442 187916 ± 487 
 
z Conclusion about optical parameters for PMT monitoring 
1) Blue LED (Ocean Optics) gives higher excitation light intensity than the incandescent light 
source and results in stronger PMT signal. 
2) Setting the internal gate time to 2sec nearly doubles the measured photon count as compared 
with 1sec.  




PMT calibration curve for insulin-FITC 
z Measured photon count for insulin-FITC standards 
Light source: blue LED;   PDMS flow cell 
λEx 494 nm, λEm 520 nm; 






25 50 350 700 
Raw 45260 47296 50393 80933 117781
Stdev 184 241 272 256 413 
Blk-corr 0 2036 5134 35673 72521 
 
z PMT calibration curve for insulin-FITC 
insulin-FITC PMT calibration curve
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